Biotechnology: 1994 report on protein engineering R & D programmes in Europe European  Commission  Directorate  -  General  XII  Science,  Research  and  Development. FINANCIAL ASPECTS R&D PROGRAMME . SCIENCE  & TECHNOLOGY ASPECTS . POLICY ASPECTS . FUTURE DEVELOPMENTS  IN: BELGIUM . DENMARK . GERMANY . GREECE . SPAIN .  FRANCE  . IRELAND . ITALY . THE NETHERLANDS . PORTUGAL UNITED  KINGDOM . AUSTRIA . FINLAND . ICELAND . NORWAY . SWEDEN . by unknown
ISSN 1018-5593 
E U R O P E A N 
C O M M I S S I O N 
Biotechnology 
L· 
\ 1994 Report 
on Protein 
Engineering R&D 
Programmes 
in Europe 
Report 
EUR 16154 EN 
Front cover 
Fusarium cutinase at pH 4.5 with positive and negative isopotential surfaces represen-
ted as solid surfaces 
Parts of the backbone here represented as a ribbon can be seen to penetrate the 
isopotential surface at several locations. The potential surfaces have been calculated 
using TITRA (Petersen and Martel) and DelPhi (Biosym Technologies). The image 
was prepared as part of a study carried out by M. Sebastião, P. Martel, A. Baptista 
and S.B. Petersen. Courtesy of the MR Center, SINTEF-UNIMED. 
European Commission 
Directorate - General XII 
Science, Research and Development 
BIOTECHNOLOGY 
1994 REPORT ON 
PROTEIN ENGINEERING R&D 
PROGRAMMES 
. CONTACT PERSON . FINANCIAL ASPECTS 
R&D PROGRAMME . SCIENCE & TECHNOLOGY ASPECTS 
. POLICY ASPECTS . FUTURE DEVELOPMENTS 
IN: 
BELGIUM . DENMARK . GERMANY . GREECE . SPAIN . FRANCE 
. IRELAND . ITALY . THE NETHERLANDS . PORTUGAL 
UNITED KINGDOM . AUSTRIA . FINLAND . ICELAND . NORWAY 
. SWEDEN . EMBL . EUROPEAN COMMISSION 
Prepared by the Protein Engineering Contact Group: 
O. Vandenput (BE), B. Clark (DK), D. Schomburg (DE), 
S. Hamodrakas (GR), A. Albert (ES), D. Moras (FR), C. Fagan (IE), 
A. Fontana (IT), G.T. Robillard (NL), J. Moura (PT), M.J. Geisow (GB), 
M. Hölbling (AT), T. Teeri (FI), A. Gudmundsdottir (IS), 
S.B. Petersen (NO), L. Pettersson (SE), C. Sander (EMBL), 
and P. de Taxis du Poet (EC) 
Edited by 
P. de Taxis du Poet 
EUR 16154 EN 
Published by the 
EUROPEAN COMMISSION 
Directorate-General XII 
Science, Research and Development 
LEGAL NOTICE 
Neither the European Commission nor any person acting on behalf of the 
Commission is responsible for the use which might be made 
of the following information 
Cataloguing data can be found at the end of this publication 
Luxembourg: Office for Official Publications of the European Communities, 1995 
ISBN 92-826-9647-2 
© ECSC-EC-EAEC, Brussels · Luxembourg, 1995 
Reproduction is authorized, except for commercial purposes, provided the source 
is acknowledged. 
Printed in Belgium 
; : 
EXECUTIVE SUMMARY 
·':*:« 

Executive Summary 
The recent Communication -COM(94) 438 final- from the Commission "Research and 
Technological Development (RTD): achieving coordination through cooperation" 
concerns the implementation of Art. 130H of the Treaty on European Union (which 
requires the Community and the Member States to coordinate their activities so as to 
ensure that national policies and Community policy are mutually consistent). This 
represents a logical follow-up of the White Paper on growth, competitiveness and 
employment, as much as it addresses one of the major weaknesses of the Community -
the fragmentation of the research activities of the Member States. 
The approach which has been followed for the sector described as Protein Engineering 
was to suggest that it might be a typical subject area (being relatively new and 
consisting of a combination of several disciplines and techniques) for review at national 
and Community levels to achieve an improved level of coordination. 
A 3-step approach has been taken : 
(1) to collect information on the national protein engineering programmes, 
(2) to share and analyze this information and find a common presentation "format" and, 
(3) to list topics for further action on the basis of this rigorous analysis of available 
data. 
This work was carried out for 16 countries, the EMBL and the European Commission, 
with the crucial help of the "Protein Engineering Contact Group" made up of contact 
persons nominated by each country. The outcome of this work is the present 1994 
report on protein engineering programmes which should be considered as the first step 
in a continuous approach towards the provision of better information to the scientific 
community, programme managers and policy makers involved in protein engineering 
R&D in Europe. 
With further improvements (such as an extension of scope towards structural biology 
and more information on industrial activities), and with the methodology developed, the 
"Contact Group" could form, together with the European Commission services, a 
crucial network to share information, as well as to improve its quality and accuracy. 
This mechanism for the coordination of research effort in Europe may become a model 
for other subjects and sectors. 
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INTRODUCTION 

Introduction 
. The principle of subsidiarity 
The "Second Commission working document concerning RTD policy in the Community and 
the 4th Framework Programme (1994-1998) of Community RTD activities" contains the 
following passage related to closer integration of research and technological development in 
Europe: 
"The principle of subsidiarity dictates that the Community should take action on research, 
only if the objectives can be better achieved by the Community than by the Member States 
acting on their own. Article 130h of the Treaty on European Union also requires the 
Community and the Member States to coordinate their activities so as to ensure that national 
policies and Community policy are mutually consistent. It must be acknowledged that not 
enough has been done on this point so far. A new approach is needed, with the detailed 
procedures tailored to each research area." 
Whatever area is chosen, an inventory would be required to identify which national and 
Community activities would best come under the scope of an harmonization of relevant S&T 
policies. In producing such an inventory, difficulties as well as opportunities would have to 
be pragmatically understood and exploited, as they would suggest which implementation 
mechanisms would allow the desired form of coordination in the area in question. 
. The European Commission White Paper 
The European Commission White Paper entitled "Growth, Competitiveness, Employment, the 
challenges and ways forward into the 21st century"2 states that Europe's research and 
industrial base suffers from a series of weaknesses: the level of financial resources and the 
application of research results are two of them. The following passage concerns the 
coordination of research: 
"A second weakness is the lack of coordination at various levels of the research and 
technological development activities, programmes and strategies in Europe. First, there is 
a lack of coordination between the national research policies., The Community's research 
budget accounts for only 4% of research spending by the 12 Member States. Even adding the 
resources allocated to joint European RTD activities in other frameworks (e.g. under Eureka, 
ESA, CERN, EMBL, etc.), the budget amounts to only 10% or so of the total. Despite the 
coordination called for by the existence of these activities and the need for the Member States 
to take them into account when defining their own policies, the national policies are still 
developed largely without reference to one another. " 
COM(93)158 final, 22 April 1993 
European Commision, Brussels - Luxembourg, 1994 
. "Research and Technoloeical Development: achieving coordination through cooperation" 
The recent Communication3 from the Commission "Research and Technological Development 
(RTD) achieving coordination through cooperation" concerns the implementation of Art. 130 
H of the Treaty on European Union and represents a logical follow-up of the White Paper 
on growth, competitiveness and employment as much as it addresses one of the major 
weaknesses of the Community - the fragmentation of RTD activities in its Member States. 
The Communication mentions in particular that: 
"A distinction must be drawn between two concepts: ft) cooperation, which is now accepted 
by everyone as the usual mechanism for the Community action, with the obvious advantages 
of voluntary pooling of efforts and skills on a case-by-case basis; fti) coordination, a 
mechanism which promises major advantages for increasing the efficiency of all RTD 
activities but which also imposes greater constraints and, hence, is harder to accept. For this 
reason, the Commission proposes a progressive approach to achieve better coordination by 
intensifying cooperation at the various stages of drafting and implementationg RTD policy ". 
The proposed approach is presented as: 
"The approach taken must be multifaceted and flexible, but also practical. Different types of 
activity will be undertaken at different levels: 
- on determination of RTD policies, with the objective of providing ministers in the Union 
with a forum for discussion with systematic preparatory work to supply the information which 
they all need; 
- on implementation of research activities, including not only those covered by the Framework 
Programme for implementing Articles 130K and 130 L but also the activities under the 
national programmes in order to make all efforts more consistent; 
- on international cooperation, where a stronger presence on the part of the European Union 
is both desirable and attainable, without impinging on the Member States' prerogatives". 
. The approach for Protein Engineering 
The approach followed here was to suggest that Protein Engineering might be a typical area 
for review at national and Community levels to achieve a good level of coordination. The 
field of protein engineering was felt appropriate, as being relatively new, and consisting of 
the combination of several disciplines and techniques. 
A 3-step approach has been taken : 
(1) to collect information on the national protein engineering programmes 
(2) to share and analyze this information and find a common presentation "format" and, 
(3) to list topics for further action on the basis of a rigorous analysis of the available data 
(gaps, duplications of effort, possible synergies, e t c . ) . 
In the first part of the report, the essential facts are presented in a summary with a common 
format, including the following parts for each country: 
- Contact person 
(from whom additional information can be obtained) 
19 October 1994 
- National programme 
(or, if there is no programme in the strict sense of the word, the way PE R&D is 
organized at the national level) 
- Policy aspects 
(including the strategic approach and priorities) 
- Financial aspects 
(appropriate caveats are given for the figures presented) 
- Science & Technology aspects 
(including the main R&D centers and S&T activities) 
- Future developments 
(programmes or initiatives in preparation) 
. Collection and analysis of information 
The crucial first step of collecting information from the different countries as well as 
improving and validating the quality and accuracy of the data was carried out with the key 
contributions from the Protein Engineering Contact Group which consists of one contact 
person (see table page 13) per country, nominated by the national delegates (see table page 
17) of the sub-group for horizontal activities of the CRN-BIOTECH (Committee of 
Regulatory Nature of the EC RTD Biotechnology programme). 
The second part of the report concerns the analysis of the information collected. It was 
prepared following intensive discussions and consultations with the Contact Group. It 
highlights the organisational and technological aspects that have contributed to the research 
programmes in protein engineering and is, to a large part, based upon cautious analysis of 
the factual data that has been provided. Common trends rather than individual exceptions are 
highlighted, except when the nature of such exceptions contains an important message for the 
report as a whole. 
P. de Taxis du Poet and E. Magnien 
8 December 1994 

DEFINITION OF 
PROTEIN ENGINEERING 

Definition of Protein Engineering (PE) 
One of the main objectives of this report is to offer to the reader (in particular, the scientists 
and policy makers) a precis of the national programmes / centers / activities in Europe, 
which could facilitate scientific collaboration as well as the coordination of research activities 
in Europe. Therefore, in view of these objectives, there are two risks in defining protein 
engineering: a too rigid definition would ignore important elements of what is considered as 
protein engineering in some countries and, a too flexible definition would include almost all 
biotechnological activities. 
To limit these risks, the PE Contact Group proposed a definition which focuses on the 
objective of PE, rather than on the diverse components / tools / disciplines necessary to reach 
this objective: The term Protein Engineering applies to any deliberate modification of a 
protein structure which brings about a change in its functional properties. 
It is clear that PE requires the integration of competences in various domains (molecular 
biology, biochemistry, computer science, techniques of 3-D determination, etc). Therefore, 
anyone of these disciplines could not be considered under the umbrella of protein 
engineering, if it was not integrated with the others. Thus, PE is defined as the integration 
of various disciplines and techniques to reach the above mentioned specific objective. 
Concerning how far we should go in each of these integrated disciplines composing Protein 
Engineering for the purposes of this report, a reasonable flexibility is allowed. Indeed, this 
diversity may reflect the different views on how important any particular discipline of protein 
engineering is considered. This additional information could be of interest to the reader, 
keeping in mind that the objective of this report is to describe the various ways the field of 
protein engineering is covered in each country. 
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"Contact Group" 
for 
Protein Engineering R & D Programmes in Europe 
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List of Contact Persons 
Country & 
Contact Person 
Belgium 
O. Vandenput 
Denmark 
B. Clark 
Germany 
D. Schomburg 
Greece 
S. Hamodrakas 
Spain 
A. Albert 
France 
D. Moras 
Ireland 
C. Fagan 
Italy 
A. Fontana 
Address 
Belgian Office for 
Scientific, Technical 
and Cultural Affairs 
Rue de la Science, 8 
BE - 1040 Brussels 
Aarhus University 
Institute of Chemistry 
Dept. of Biostructural 
Chemistry. 
DK - 8000 Aarhus C 
Gesellschaft fur 
Biotechnologische 
Forschung mbH(GBF) 
Mascheroderweg 1 
DE - 38124 
Braunschweig 
University of Athens 
Dept. of Biochemistry 
GR - 157 01 Athens 
C.I.C.Y.T 
Plan Nacional de 
I + D 
c/Rosario Pino 14/16. 
6c pianta 
ES - 28020 Madrid 
IGBMC - Biologie 
Structurale 
1, rue Laurent Fries 
BP 163 
FR - 67404 IUkirch 
Dublin City University 
School of Biological 
Sciences 
IE - Dublin 9 
CRiBI Biotechnology 
Center 
Via Trieste, 75 
IT-35121 Padova 
Tel, Fax & Email 
Tel: +32 2 2383519 
Fax: +32 2 2305912 
Email: Olivier.Vandenput@belspo.rtt.be 
Tel: +45 89423333 
Fax: +45 86196199 
Email: clark@biobase.dk 
Tel: +49 53161810 
Fax: +49 5316181515 
Email: schomburg@venus.Gbf-hraunschweig.d400.de 
Tel: +301 7284545 or 7240091 
Fax: +301 7231634 
Email: sbamodr@atlas.uoa.ariadne-t.gr 
or 
hamodrakas@rea.di.uoa.ariadne-t.gr 
Tel: +34 15720098 
Fax: +34 13360435 
Tel: +33 88653351 
Fax: +33 88653203 
Email: moras@ibmc.u-strasbg.fr 
Tel: +353 17045288 
Fax: +353 17045412 
Email: faganc@vaxl.dcu.ie 
Tel: +39 498286667 
Fax: +39 498286659 
14 
The Netherlands 
G.T. Robillard 
Portugal 
J. Moura 
United Kingdom 
MJ. Geisow 
Austria 
M. Holbling 
Finland 
T. Teeri 
Iceland 
A. Gudmundsdottir 
Norway 
S. B. Petersen 
Sweden 
L. Pettersson 
EMBL 
C. Sander 
European 
Commission 
P. de Taxis du Poet 
University of 
Groningen. Dept. of 
Chemistry 
Nijenborg, 4 
NL - 9747 AG 
Groningen 
Universidade Nova de 
Lisboa 
Faculdade de Cièncas e 
Tecnologia 
PT - 2825 Monte da 
Caparica 
BIODIGM 
Langdale Grove 64 
Bingham, Notts 
UK - NG13 8SS 
Büro für Internationale 
Forschungs-und 
Technologie 
kooperationen. 
Wiedner Hauptstrasse 
76 
AT - 1042 Wien 
NTT/Biotechnology 
and Food Research 
PO Box 1503 
FI - 02044 VTT 
University of Iceland 
Science Institute 
Dunhagi 3 
IS - 107 Reykjavik 
SINTEFax: 
UNIMED.MR-Center 
NO - 70034 Trondheim 
NUTEK 
SE-117 86 Stockholm 
EMBL 
Meyerhofstraoe 1 
D-69012 Heidelberg 
European Commission 
DG XII-E-1 
(Biotechnology) 
Rue de la Loi, 200 
Β-1049 Brussels 
Tel: +31 50634321/634203 
Fax: +31 50634165 or 634200 
Email: g.t.robillard@cbem.rug.nl 
Tel: +351 12954464 
Fax: +351 12954461 
Tel: +44 949839077 
Fax: +44 949831886 
Email: mbgei@seqnet.dl.ac.uk 
Tel: +43 15811616107 
Fax: +43 1581161616 
Email: bit-austria@bit.aconet.ada.at 
Tel: +358 04565110 
Fax: +358 04552103 
Email: Tuula.Teeri@vtt.fi 
Tel: +354 1694796 
Fax: +354 128911 
Email: ag@raunvis.hi.is 
Tel: +47 73997700 
Fax: +47 73997708 
Email: sbp@marvin.mr.sintef.no 
Tel: +46 86819346 
Fax: +46 8196826 
Tel: +49 6221387361 
Fax: +49 6221 387306 
Email: sander@EMBL-Heidelberg.de 
Tel: +32 22954043 
Fax: +32 22955365 
Email: p.de-taxis-du-poet@mhsg.cec.be 
CNR-BIOTECH 
Sub-Group for 
Horizontal Activities 
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Members of the sub-group for horizontal activities 
of the 
Regulatory Committee for the EC RTD programme in the field of 
Biotechnology 
(1990-94) 
BELGIUM 
J. De Brabandere 
DENMARK 
M. Bennum 
GERMANY 
E. Warmuth 
GREECE 
K. Drainas 
SPAIN 
A. Albert 
FRANCE 
P. Printz 
IRELAND 
J. Ryan 
ITALY 
A. Albertini 
LUXEMBURG 
P. Decker 
THE NETHERLANDS 
M.W. Homing 
PORTUGAL 
J.M. Novais 
UNITED KINGDOM 
P. Vaughan 
AUSTRIA 
C. Fialla 
FINLAND 
P. Nybergh 
ICELAND 
J.K. Kristjansson 
NORWAY 
R. Torgensen 
SWEDEN 
G. Öquist 
COMMISSION 
Chairman : E. Magnien ; Secretariat : P. de Taxis du Poet 
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BELGIUM 
Dr. 0 . Vandenput 
Belgian Office for Scientific, 
CONTACT PERSON 
Technical and Cultural Affairs 
Rue de la Science, 8, BE-1040 Brussels 
Tel: 32 2 2383519 
Fax: 32 2 2305912 
Email: vdpu@smtp.belspo.be 
NATIONAL PROGRAMMES 
R&D policy has been progressively partially decentralized in Belgium. Therefore 
support for protein engineering is organized at the federal and regional levels, under the 
following programmes: 
. Incentive programme for fundamental research in life sciences (federal) 
. Inter-university poles of attraction (federal) 
. Flemish action programme on biotechnology (regional) 
. 3 Walloon programmes related to biotechnology (regional) 
. French community programme 
. Fonds National de la Recherche Scientifique (FNRS) 
POLICY ASPECTS 
. To underpin the growth of different fields in the biosciences and to create inter-
university poles of attractions or networks in basic research (federal level) 
. To stimulate R&D initiatives in specific fields of biotechnology and the transfer of 
existing knowledge and technology from universities to industry (Flemish region) 
. To allow young researchers to acquire a complementary S&T training in university 
and industry, and to stimulate the collaboration between universities and industries 
(Wallonian region) 
FINANCIAL ASPECTS 
The amounts indicated include salaries, equipment, consumables, travel costs and 
overheads. 
Incentive programme for fundamental 
research in life sciences 
3.6 MECU (6 projects, 1988-1993) 
22 
Inter-university poles of attraction 
Flemish action programme on 
biotechnology 
French community programme 
Walloon programmes related to 
biotechnology 
5.08 MECU (2 projects, 1990-1995) 
Total of 22 MECU (1990-1995): 
A portion (3.5 MECU) is devoted to 
protein engineering (3 projects) and there 
is one centre for emerging technology 
(3.8 MECU, 1990-1997) 
1 MECU / 5 years 
0.72 MECU over a period of 2 to 3 years 
depending on the project 
SCIENCE &TECHNOLOGY ASPECTS 
Incentive programme for fundamental 
research in life sciences 
Inter-university poles of attraction 
Flemish action programme on 
biotechnology 
French community programme 
- structure-function relationships of a cell 
growth factor 
- NMR technology 
- membranes proteins in yeasts and plants 
- Enzyme solution dynamics 
- peptide-protein interactions 
- High-sensitive sequence analysis of 
proteins 
- penicillin binding proteins 
- Development of new anti-cancer 
therapeutics (TNF and IFN) 
- Molecular farming: the production of 
bioactive peptides in the seeds of 
transgenic plants by engineering the 2S-
albumine stock proteins 
- Cloning and expression of human 
receptor genes 
- Molecular modelling of human 
lymphocyte dipeptidyl peptidase IV 
- antibody engineering 
- protein-carbohydrate interactions 
Concerted actions on the enzymes of 
organisms living at low temperatures 
(trypsines, subtilisines, amylase and 
lactamase) 
23 
Walloon programmes related to 
biotechnology 
- Membrane protein of Schistosoma 
monsoni 
- Neuronal proteins 
- Lipase 
- Adrenergic receptors 
- Neuropeptides 
- Human receptors 
- Antigens of Varicella zoster virus, 
paramyxovirus and Toxoplasma gondii 
- Apolipoprotein Al 
- Prolactins 
- Selection methods for enzymes with new 
properties 
FUTURE DEVELOPMENTS 
No information available 
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DENMARK 
CONTACT PERSON 
Prof. B. Clark 
Aarhus University, Institute of Chemistry, Dept. of Biostructural Chemistry 
8000 Aarhus C. Denmark 
Tel: 45 89423333 
Fax: 45 86196199 
Email: clark@biobase.dk 
NATIONAL PROGRAMME 
The Danish protein engineering research centre (PERC) was established as a formal 
collaboration, within the context of the Danish biotechnological R&D programme 1991-
1995 (Biotek II), between 4 groups: 
- Odense university, protein structure and function unit 
- Aarhus university, laboratory for macromolecular structure 
- Aarhus university, laboratory for recombinant protein chemistry 
- Carlsberg laboratory, protein structure and NMR group 
POLICY ASPECTS 
The idea is to combine scientific and methodological expertise into a common endeavour 
aimed at an increased understanding of the structure-function relationships, and 
ultimately to the elucidation of general principles which allow prediction of the 
structural change needed to obtain a desired functional alteration. Achievement of this 
general goal is planned through a common project entitled: "Systematic protein 
engineering studies of protein domains in single and multi-domain proteins" 
FINANCIAL ASPECTS 
A total of 4.5 MECU (1991-1993) with approximately 60% from the BIOTEK 
programme, and 40% from other sources. (This does not include salaries for permanent 
staff and infrastructure costs). 
28 
SCIENCE & TECHNOLOGY ASPECTS 
The 4 PERC participants have developed interactions between the groups and nearly all 
national and many international research groups involved in protein engineering. PERC 
was invited to become a founding member of the international network of protein 
engineering centres (INPEC) in 1991. The 4 main research groups are: 
-Odense university, protein structure and 
function unit 
Coordinator: P. Roepstorff (also PERC 
leader) 
-Aarhus university, laboratory for 
macromolecular structure 
Coordinator: B.F.C. Clark 
-Aarhus university, laboratory for 
recombinant protein chemistry 
Coordinator: H.C. Thøgersen 
-Carlsberg laboratory, protein structure 
and NMR group 
Coordinator: F.M. Poulsen 
-Development of mass spectrometric 
methods for protein analysis and 
structure/function studies of acyl 
coenzyme A binding protein (ACBP) 
-The explanation of the function of 
elongation factor (EF-Tu) arising from 
structural determination of its different 
conformational states and mutants 
-Folding, structure and function of 
domains from multi-functional proteins 
-Protein structure NMR spectroscopy and 
protein engineering 
Supporting technology: BioBase - The Danish EMBnet Node 
E-mail contact: hum@biobase.dk 
Contact person: Hans Ullitz Møller, BioBase, Ole Worms Allé, Bid. 170, Aarhus 
University, 8000 Aarhus C, DK, Tel. +45 8942 2846, Fax. +45 8613 1160 
BioBase is a comprehensive service facility established for the Danish biotechnological 
research community that offers a large set of updated databases and a broad spectrum of 
sequence analysis programmes. These features, in connection with the European 
EMBnet nodes, offer opportunities that are essential for the modem researcher. Thus, it 
is possible to investigate if a new sequence contains elements that are either identical, or 
have a certain similarity, to elements of already known sequences. National funding for 
BioBase is 0.26 MECU per year. 
FUTURE DEVELOPMENTS 
The projects will be continued as planned, taking into account development in the 
international scientific society. A very important effect of the PERC collaboration is that 
all participants have widened their horizons, through the contacts and collaborations, 
and have been inspired to plan the next generation of projects to be initiated and 
problems to be solved. 
GERMANY 
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GERMANY 
CONTACT PERSON 
Prof. D. Schomburg 
Gesellschaft für Biotechnologische Forschung mbH (GBF) 
D-38124 Braunschweig 
Tel: 49 531 6181 0 
Fax: 49 531 6181 515 
Email: Schomburg®VENUS.GBF-Braunschweig.D400.DE 
NATIONAL PROGRAMME 
.There is no specific protein engineering programme but this sector is covered by the 
biotechnology programme "Biotechnology 2000" 
•The national funding programme (BMFT) on "Molecular Bioinformatics" partly 
concerns (theoretical) protein engineering related activities 
POLICY ASPECTS 
Biotechnology 2000 states that the main focus of support is on projects dealing with the 
development of methods of protein structural analysis and molecular modelling. Also, a 
priority are methods for the simulation of structure and dynamics of complex molecules 
and methods for the design of proteins with new properties. 
FINANCIAL ASPECTS 
•A total of 16 MECU is dedicated to the protein engineering sector (66 % from the 
federal government), which includes 18 research projects (from 1 to 5 years) covering 
the 1987-1992 period. Six new projects (1.5 MECU) werelaunched in 1992 
• In the "Molecular Bioinformatics" programme (11.4 MECU in three years), 40 % 
(4.56 MECU) is for protein engineering 
The amounts given above are additional costs directly related to the research projects 
(including salaries, investments, consumables, travels, etc.). This is "project money" 
spent by the central federal government. Details of the money spent on protein 
engineering projects by the research institutes, Max-Planck Institutes and universities 
from their institutional money or by the "Deutsche Forschungsgemeinschaft", are not 
available. 
32 
SCIENCE &TECHN0LOGY ASPECTS 
National Centres 
Protein X-ray 
Groups 
Protein NMR 
Groups 
- GBF (Gesellschaft für Biotechnologische Forshung) houses the 
"Centre of Applied Protein Engineering", CAPE, Prof. D. 
Schomburg, Braunschweig 
- Institut für Molekulare Biotechnologie, Jena, Prof. Schuster 
- MPI für Medizinnische Forshung, Prof. K. Holmes, Heidelberg 
- Max-Planck Institut für Biochemie, Prof. R. Huber, 
Martinsried 
- FU Berlin, Institut für Kristallografie, Prof. W. Saenger, Berlin 
- Universität Freiburg, Institut für Biochemie, Prof. G. Schultz, 
Freiburg 
- GBF, Molecular structure research, Prof. D. Schomburg, 
Braunschweig 
Two new groups to be installed: 
- Max-Delbrück Zentrum, Dr. U. Heinemann, Berlin-Buch 
- Institut für Molekulare Biotechnologie, Dr. R. Hilgenfeld, Jena 
- Max-Planck Institut für Biochemie, Dr. T. Holak, Martinsried 
- Universität Frankfurt, Institut für Organische Chemie, Prof. 
Griesinger, Frankfurt/main 
- Technische Universität München, Institut für Organische 
Chemie, Garching 
- Universität Frankfurt, Institut für Biophysikalische Chemie, 
Prof. Rüterans, Frankfurt/main 
- Universität Bayreuth, Lehrstuhl für Struktur der Biopolymere, 
Prof. Roesch, Bayreuth 
- GBF, Molecular structure research, Prof. D. Schomburg, 
Braunschweig 
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Protein Modelling 
Sofware and 
method 
development 
Development of 
Protein Data 
Banks 
- GBF, Molecular structure research, Prof. D. Schomburg, 
Braunschweig 
- GMD II, Prof. T. Lengauer, St. Augustin 
Protein Sequences: 
- MIPS, Dr. W. Mewes, Martinsried 
Enzyme information: 
- GBF, Molecular structure research, Prof. D. Schomburg, 
Braunschweig 
FUTURE DEVELOPMENTS 
There is a new programme: "Techniques for the decoding and use of biological 
design". 

GREECE 
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GREECE 
CONTACT PERSON 
Prof. S. Hamodrakas 
Dept. of Biochemistry, University of Athens, Cell and Molecular Biology and Genetics 
GR-157.01 Athens 
Tel: 30 1 7284545 or 7240091 
Fax: 30 17231634 
Email: shamodr@atlas.uoa.ariadne-t.gr or hamodrakas@rea.di.uoa.ariadne-t.gr 
NATIONAL PROGRAMME 
There is no specific protein engineering programme but related projects receive support 
from the Greek Ministry of Research and Technology 
POLICY ASPECTS 
No information available. 
FINANCIAL ASPECTS 
The financial support obtained from National Sources is very small, and therefore much 
depends on European collaborations and funding from the EEC, which are both very 
limited. Support from industry is almost non-existent. 
SCIENCE &TECHNOLOGY ASPECTS 
The most relevant research group are: 
Dept. of Biochemistry 
University of Athens 
Dr. Moudrianadis 
Dr. Hamodrakas 
National Science Foundation 
Athens 
Dr. Oikonomakos 
Dr. Kolisis 
- Protein folding and prediction 
- Bioinformatics 
- Structural studies of protein-
carbohydrate interactions 
- Metalloproteins, enzymes, and fibrous 
proteins. 
- Nucleosome structure 
- Carbohydrate active enzymes (glycogen 
Phosphorylase). 
- Lipases 
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Institute Pasteur 
Athens 
Dr. Tzartos 
Agricultural University of 
Athens 
Dr. Eliopoulos 
Dept. of Biochemistry 
University of Ioannina 
Dr. Sakarellos 
Dr. Gerothanasis 
Department of Biologya 
IMBB, Heraclion, Crete 
Dr. Kokkinidis 
Dr. Petratos 
National Research Centre 
Demokritos 
Dr. Petrouleas 
Dr. Stassinopoulou 
- Antibody-antigen interactions 
- Receptors 
- Bioinformatics, Data Bases 
- NMR studies of pharmacological 
peptides, heme proteins and enzymes 
- o-helical bundle proteins 
- DNA bindingproteins 
- Metalloproteins 
- ESR studies of photosystem II 
- NMR studies of carbohydrate binding 
proteins 
No information available 
FUTURE DEVELOPMENTS 
SPAIN 
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SPAIN 
CONTACT PERSON 
Prof. A. Albert 
CICYT, Plan Nacional de I&D, c/Rosario Pino 14-16, 6è planta, E-28020 Madrid 
Tel: 34 1 5720098 
Fax: 34 1 3360435 
Email: 
NATIONAL PROGRAMME 
There is no specific programme on protein engineering, but related projects receive 
support from 2 main sources: 
. The general programme for the Enlargement of Science, GPES (fundamental 
research) 
. The national Programme of Biotechnology (oriented research) 
POLICY ASPECTS 
The principal gaps or problems to be solved are the limited number of research groups 
working on crystallography (2), protein design (2), NMR (2) and the lack of integrated 
work or the dispersion of scientific aims. 
FINANCIAL ASPECTS 
During the period 1990-94, the National Programme if Biotechnology has financed 
research projects on protein sciences for about 5 MECU. However, considering that 
other research projects in this field have been financed in other programmes, mainly in 
the Programme for General Promotion of Knowledge (basic science), we estimate that 
Spain has supported, during the period 1990-94, research projects on protein sciences 
for about 10 MECU. 
This amount does not include infrastructure costs. To calculate this amount, we have 
considered as projects related to protein science, those ones which concern the 
production, utilization or characterisation of proteins or polypeptides, and not only those 
related to protein engineering. 
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SCIENCE &TECHNOLOGY ASPECTS 
The national R&D Plan has created 2 national networks on: 
. Protein structure, folding and stability (coordinated by Prof. M. Rico) 
. Computational analysis of structure and evolution of biological macromolecules 
(coordinated by Prof. J.M. Carazo, Centro Nacional de Biotecnologia, Madrid): 
- Possible evolutive relationships in protein sequences 
- Useful models for system operations 
- Three-dimensional structures at different levels of resolution 
- New generation of parallel computer algorithms 
The main centres, in which several groups work on protein engineering, are located 
Madrid and Barcelona: 
Madrid 
- Centro Nacional de Biotecnologia, 
- Centro de Biologia Molecular 
- Centro de Investigaciones Biológicas, 
- Instituto de Química Fisica 
- Instituto de la Estructura de la Materia, 
- Instituto de Catálisis y Petroquímica, 
- Depart, de Bioquímica y Biologia 
Molecular, Univ. Complutenses of 
Madrid 
- Depart, de Bioquímica y Biologia 
molecular, Autonomous Univ. of Madrid 
- Centro Pluridisciplinar UCM 
Barcelona 
- Instituto de Biologia Fundamental, 
- Centro de Investigación y Desarrollo 
- Depart, de Bioquímica y Biologia 
Molecular, Autonomous University of 
Barcelona 
- Depart, de Ingenieria Química, 
Politecnica University of Barcelona 
- Dept. Ingeneria Química, Autonomous 
University of Barcelona 
- Electron microscopy 
- Database & Bioinformatics 
- X-ray diffraction 
- NMR 600 MHz 
- Electron microscopy 
- Electron microscopy 
- Electron microscopy 
- NMR 600 MHz 
- X-ray diffraction, NMR 
- Mass spectrometry 
- X-ray diffraction 
in 
FUTURE DEVELOPMENTS 
. The Higher Council of Scientific Research (CSIC) is currently drawing 
programme on protein engineering 
up a special 
FRANCE 
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FRANCE 
CONTACT PERSON 
Dr. D. Moras 
IGBMC / Biologie Structurale 
1, rue Laurent Fries, BP 163, FR-67404 Illkirch Cedex 
Tel: 33 88653351 
Fax: 33 88653203 
Email: MORAS@IBMC.U-STRASBG.FR 
NATIONAL PROGRAMMES 
Three national programmes were launched in the early nineties. Two of them are now 
completed: 
•IMABIO (Ingénierie des Macromolécules Biologiques) was launched by the CNRS 
(Centre National de la Recherche Scientifique) in 1990 for a four year period which 
ended in 1994. 
•PROTEINE 2000 was launched in January 1989 by the CEA (Commissariat à 
l'Energie Atomique). 
• CM2AO (1991-1993) (Conception et Modélisation des Macromolécules) consists of 5 
companies (BSN, Limagrain, Orsan, Rhône-Poulenc and Roussel UCLAF) and aims at 
the development of generic methods necessary for the creation and modélisation of 
biological macromolecules. 
POLICY ASPECTS 
• A priority: Protein engineering is considered a priority by the Ministry of Research, 
the main national research organisations, and the industry, particularly in the 
pharmaceutical sector. 
•Integration: The first national initiative began with the 1982-1988 period of the 
biotechnology programme, aiming at integrating the different skills required. 
•Limited number of centres: In 1990, the relay was taken up by national institutions 
(in particular CNRS and CEA). A limited number of centres were created, bringing 
together all necessary technical tools and aiming at technological applications. 
•An industrial initiative: Industry has launched the CM2AO programme in which 5 
companies are involved. The public services are supporting this initiative (50% from 
industry). 
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FINANCIAL ASPECTS 
IMABIO 
PROTEINE 2000 
CM2AO 
26.7 MECU (1990-1994) equally 
distributed between equipment and 
construction cost for the 4-year 
programme 
17.1 MECU (for 1994), salaries and 
running expenses included 
2.4 MECU (1991-1993), salaries and 
running expenses included 
SCIENCE &TECHNOLOGY ASPECTS 
. IMABIO investment was concentrated in 7 centers, one of them (IBS, in Genoble) in 
partnership with the CEA. Each center has its own scientific character. The manpower 
of these research centers amounts to 359 staff scientists, 207 from CNRS , 15 from 
INSERM and 137 from the universities. 
. PROTEINE 2000 involves 4 scientific departments of CEA, 3 in Saclay and one in 
Grenoble, and the Institut de Biologie Stucturale (IBS, Grenoble). All together, 155 
scientists from CEA are involved. All the classical aspects of protein engineering are 
covered. An interesting and unique feature of the programme is the large investment in 
the field of molecular labelling using tritium, stable and radioactive isotopes or 
chemicals. 
. The main research centres are: 
Institut de Biologie Structurale, Grenoble 
Saclay 
Access to the European synchroton 
(ESRF) 
Protein-protein and protein-nucleic acid 
interactions 
Structural enzymology, protein folding 
Molecular modélisation 
Molecular labelling: national units and/or 
facilities for labelling of biomolecules 
with isotopes. 
Engineering of receptor-ligands, enzymes 
inhibitors and chimeric antibodies. 
Drug delivery and targeting 
Structure-function of proteins, protein 
foding 
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Gif - Orsay 
Centre de Biochimie Structurale, 
Montpellier 
Institut de Biologie et Chimie des 
Protéines, Lyon 
Strasbourg 
Marseille 
Toulouse 
Access to electro-magnetic radiation 
sources (LURE) 
Structure of peptides and proteins 
Macromolecular interaction 
Structural enzymology and immunology 
Structure and interaction of proteins 
Protein crystallisation 
Structure-function of proteins and protein 
chaperons 
Post-translational modifications 
structure and engineering of collagen 
Structure of macromolecules involved in 
gene expression 
Production of recombinant proteins, 
purification and structural analysis of 
lipolytic enzymes 
Structure-function of macromolecules, 
with regards to pharmaceuticals 
Bioinformatics support is provided by the CNRS research group on "genomes et 
informatique" which includes 16 laboratories and involves 50 researchers. 
FUTURE DEVELOPMENTS 
The CNRS is presently considering a continuation of IMABIO long term goals, through 
a new programme at the interface between chemistry and biology. 
The CEA has just approved the scientific orientation of PROTEIN 2000 in three 
directions: 
- Structural analysis of proteins and their interactions, 
- New developments in the field of labelling of biomolecules using chemical, enzymatic 
and genetic approaches, 
- Structure-function of proteins and design of new biomolecules 

fililí?!?:: 
IRELAND 
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IRELAND 
CONTACT PERSON 
Dr. C. Fagan 
School of Biological Sciences, Dublin city University, Dublin 9 
Tel: 353 1 7045288 
Fax: 353 1 7045412 
Email: faganc@vaxl.dcu.ie 
NATIONAL PROGRAMME 
There is no programme for protein engineering specifically. The State agency Forbairt 
administers: 
- the National Scientific programme and, 
- the Strategic Research programme. 
The State also funds many relevant projects through: 
- Bio Research Ireland, 
- Teagasc (agriculture) and the 
- Health Research Board. 
POLICY ASPECTS 
•The Scientific and Strategic Research programmes were relaunched in 1994. Very few 
new projects were funded in 1993. The Strategic scheme is targeted at particular sectors 
with commercial potential and helped set up the Irish National Centre for Bio-
informatics (INCBI) in 1993. 
•There is also a Collaborative Research fund for industry/third level joint projects. 
Forbairt, the State agency for indigenous industrial development, administers these 
programmes. 
•Bio Research Ireland was set up in 1987 to implement the National Biotechnology 
Programme and is now a division of Forbairt. It engages in commercial research on 5 
campuses in specific areas (cell culture, diagnostics, pharmaceuticals, food and 
veterinary sciences). 
•Teagasc is the State body for agricultural R&D. 
•The Health Research Board is entirely State funded 
• Industrial policy has targeted pharmaceuticals and fine chemicals; R&D grants are 
made directly to firms making protein products. 
•Political responsibility rests with the junior minister for commerce and technology. 
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FINANCIAL ASPECTS 
The amounts mentioned below do not include salaries or infrastructure costs. These 
funds cover projects of 2 years' duration. No amount is specifically set aside for 
protein engineering. 
- Scientific Research Programme (1990-
94) 
- Strategic Research Programme (1990-
94) 
- Bio Research Ireland 
- Teagasc 
- 0.35 MECU per year (40% of total 
funding) for biotech./life sciences 
- 0.12 MECU per year (12.5% of total 
funding) for biotech./life sciences 
- 0.25 MECU per year on protein projects 
- 0.39 MECU per year on food protein 
projects 
SCIENCE &TECHNOLOGY ASPECTS 
- Protein crystallography group 
(T. Higgins) 
- Site-directed mutagenesis 
(S.G. Mayhew, M. Worral, J.P.G. 
Malthouse and P.C. Engel) 
- Serpin structure/function (M. Worrall) 
- Molecular modelling (G. Grant) 
- Receptor cloning (F. Martin) 
- Antibody engineering (R. O'Kennedy) 
- Protein stability and modification (C. 
Fagan) 
- Site-directed mutagenesis of 
Staphylococcus aureus epidermolytic toxin 
(C. Bailey) 
- Irish National Center for Bioinformatics 
(INCBI), (A. Lloyd) 
- Membrane proteins as vaccine antigens 
- Cloning of fibrinogen binding protein 
and a metalloprotein (D.C. Williams) 
- Homology modelling research 
(D. Sheehan) 
- University College Galway 
- University College Dublin 
- Dublin City University 
- Trinity College Dublin 
University College Cork. 
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FUTURE DEVELOPMENTS 
Academics lobbied successfully for a restoration of science funding following drastic 
cuts in 1993. The junior minister for commerce and technology has appointed a 19-
member committee of scientists, industrialists and public servants to review national 
policy. Its report is due by 31/12/1994. This will lead to a White Paper (government 
policy document). 

-ITALY 
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ITALY 
CONTACT PERSON 
Prof. A. Fontana 
CRIBI Biotechnology Center 
Via Trieste, 75, 35121 Padova, Italy 
Tel: 39 49 828 66 67 
Fax: 39 49 828 66 59 
Email: 
NATIONAL PROGRAMME 
There is no specific programme in protein engineering but there are two initiatives 
partly supporting the protein engineering sector: 
- Target project "Biotechnology and Bioinstrumentation" - BTBS -, 1988-1992 
- Advanced biotechnology, 1989- 1993 
- Neurobiology, 1992-1996 
POLICY ASPECTS 
The protein engineering sector is split into several programmes containing a wide 
range of areas with basic or applied oriented tasks 
FINANCIAL ASPECTS 
Target project "Biotechnology and 
Bioinstrumentation", 1988-1992 
Advanced biotechnology, 1989- 1993 
Neurobiology, 1992-1996 
5.3 MECU (12 % of the total budget) is 
dedicated to protein engineering 
24.8 MECU (22.5 % of the total budget) 
is dedicated to areas related to protein 
engineering 
A fraction of the total budget (56.4 
MECU) is dedicated to protein 
engineering 
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SCIENCE &TECHNOLOGY ASPECTS 
The three national programmes developing activities related to protein engineering are: 
Target project "Biotechnology and 
Bioinstrumentation " 
Advanced biotechnology 
Neurobiology 
Molecular and cellular engineering project 
including: 
- Protein engineering of polyfunctional 
enzymes, chimeric recombinant proteins 
- Characterization of enzymes and of the 
metabolism of organisms living in 
extreme conditions 
- Metabolic engineering, with particular 
emphasis on design of cytotoxic tissue-
specific drugs 
- Research into natural factors having 
potential pharmacological activity 
Specific projects on: 
- Innovative enzymes 
- Enzymes for food industry 
- Pharmacological peptides 
Some of the research projects are oriented 
to protein engineering because the 
programme approach is at molecular level 
FUTURE DEVELOPMENTS 
No information available. 
THE NETHERLANDS 
:; 
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THE NETHERLANDS 
CONTACT PERSON 
Prof. G.T. Robillard 
University of Groningen, Dept. of Biochemistry, Nijenborgh 4 
9747 AG Groningen, NL 
Tel: 31 50 634203 
Fax: 31 50 634165 or 634200 
Email: G.T.ROBILLARD@CHEM.RUG.NL 
NATIONAL PROGRAMME 
The first national protein engineering programme ran from 1986-1992 and was followed 
by a small interim programme from 1992-1994 to bridge the gap with a new programme 
which began in the second half of 1994. This is a separate programme which is part of 
a much larger national Biotechnology programme. 
POLICY ASPECTS 
An industrial lobby representing all of the major biotechnology companies in The 
Netherlands has produced an assessment of expected developments through to the year 
2000 and the initiatives needed in fundamental research to ensure these developments. 
Four themes were indicated, one being fundamental research in the structure and 
function of proteins via protein engineering. 
GBB has been selected to coordinate this programme because of Groningen's long 
tradition in protein structure research and because it was the center of previous protein 
engineering programmes. 
FINANCIAL ASPECTS 
4.6 MECU has been allocated to protein engineering research for the period 1994-
1998. The funding is allocated for salaries for 25 graduates students and/or post-docs 
who will be carrying out the protein engineering projects and for consumables for this 
research. 50% of the funding originates from the Ministry of Economic Affairs and 
50% from the universities and institutes already involved in protein engineering 
research 
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The Netherlands has invested heavily in all major areas of protein structure research. At 
the GBB (Groningen) alone, there is a full range of protein structure determination 
research facilities with each facility being incorporated in an active research group. 
These facilities include X-ray, electron microscopy, NMR, and molecular dynamics 
simulations. 
Other centers in the country are also equipped with NMR for protein structure 
determination, including a 750 MHz NMR spectrometer at the Bijvoet Institute in 
Utrecht. Two other facilities are also being established for X-ray diffraction protein 
structure determination 
SCIENCE &TECHNOLOGY ASPECTS 
. Major principal protein engineering investigators: 
- Prof. G. Canters, University of Leiden 
- Prof. L. Dijkhuizen, GBB 
- Prof. B. Dijkstra, GBB 
- Prof. D. Janssen, GBB 
- Prof. W. Konings, GBB 
- Prof. A. de Kok, Agricultural University Wageningen 
- Prof. G. Robillard, GBB 
- Prof. G. Venerna, GBB 
- Prof. H. Verheij, University of Utrecht 
. The first protein engineering activities were centred at the university of Groningen. 
Groups from the departments of biochemistry, biophysics, microbiology and genetics 
covered the whole cycle of protein engineering: 
- cloning, sequencing and mutagenesis 
- protein over expression, purification and characterization 
- structure determination, X-ray diffraction and NMR 
- molecular dynamics calculations and predictions 
, The main areas were: 
engineering of penicillin binding proteins 
engineering of neutral protease 
engineering of cyclodextrin glycosyl transferase 
engineering of dehalogenase 
engineering of the alkane oxidase system 
engineering of membrane bound transport proteins 
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FUTURE DEVELOPMENTS 
. The new programme will cover the following themes: 
- engineering of enzymes of importance as industrial biocatalysts 
- engineering of antibiotic proteins for the food and feed sector 
- protein folding and export 
- protein engineering of medically important transport and receptor proteins 
- de novo protein design 
. In addition to this national programme in preparation, two new activities are initiated 
in GBB: 
- a protein engineering facility for the purpose of doing pre-competitive and contract 
research. The facility brings in additional scientific and support personnel plus the extra 
research facilities necessary to complete the entire protein engineering cycle in house 
- a program in molecular nanostructure engineering. This project aims to build on the 
current expertise and develop technologies not yet available to achieve the goals of 
molecular nanostructure engineering -the making of entirely new macromolecular and 
supramolecular structures from small building blocks and being able to control their 
activities or function by electrical or optical signals and corresponding switching 
devices. Protein engineers, material science engineers and organic chemists are 
collaborating in this project. 
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PORTUGAL 
CONTACT PERSON 
Prof. J.J.G. Moura 
Departamento de Química, Faculdade de Ciências e tecnologia 
Universidade Nova de Lisboa 
2825 Monte de Caparica, Portugal 
Tel: 351 1 2954464 ext 3209 
Fax: 351 1 2954461 
Email: gaia@individual.puug.pt 
NATIONAL PROGRAMME 
There is no specific programme for protein engineering. However, the topic is included 
in the 4-year general Science Programme (PRAXIS XXI) that will begin in 1995, under 
the title Applied Biology and Biotechnology. 
POLICY ASPECTS 
The aims of this general science programme are: 
- to increase Portugese participation and involvement in EC projects; 
- to increase the number of young Ph.D students, as well as post-doctoral positions; 
- to consolidate the relationships between universities and industry and; 
- to allow the insertion of researchers into the field of production. 
FINANCIAL ASPECTS 
Under the PRAXIS XXI Programme, the area Applied Biology and Biotechnology will 
receive 1.3 MECU per year over a period of 4 years (1994-1999). Approximately 40% 
of this budget will be devoted to protein science and engineering. 
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SCDZNCE &TECHNOLOGY ASPECTS 
The most relevant research groups and projects are: 
Instituto de Ciências Biomédicas Abel 
Salazar, Porto 
- P.M. Ferreira 
- M.J. Saraiva 
- CE. Sunkel 
- A.M. Damas 
Faculdade de Ciências, Universidade do 
Porto, Porto 
- J.A.N. Ferreira Gomes 
- M.J. Ramos 
Instituto Tecnologia Química e Biológica, 
Oeiras 
- A.V. Xavier 
- M. H. Santos 
- M.A. Carrondo 
- M. Carrondo 
- M. Teixeira 
Departamento Bioquímica, Universidade 
de Coimbra, Coimbra 
- C F . Geraldes 
- E. Pires 
- R. Brito 
- C. Faro 
Instituto Superior Técnico, Lisboa 
- J.S. Cabral 
- R.A. Barros 
- Molecular characterization of proteins of 
the yeast cell wall 
- Recombinant proteins from Fasciola 
hepática 
- Molecular studies of transthyretin 
variants 
- Molecular studies on protein kinases 
required during mitosis in higher 
eucaryotes 
- Structural and functional studies of 
mutants transthyretin proteins 
- 3-D structural studies of some proteins 
of the yeast cell wall 
- Structural and functional studies of 
serine proteases 
- Quantitative studies of enzyme-inhibitor 
binding interaction 
- Drug design 
- Novel haem-based catalysts 
- Biotechnology of extremophyles 
- Lactic acid biotechnology 
- X-ray 3-D structures of cytochromes 
and iron-sulphur proteins 
- Structure and function of proteases 
- Structure and function of cell receptors 
- Studies on proteins surfaces (Lysozyme 
and Cytochrome C) 
- Studies on protein unfolding 
- Stability and behaviour of recombinant 
lipolytic enzymes in organic solvents 
- Lipases 
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Faculdade Ciências e Tecnologia, 
Universidade Nova de Lisboa, 2825 
Monte da Caparica 
- J. J. G. Moura 
- I. Moura 
- J. Lampreia 
- P. Mata 
- Dinuclear and polynuclear metal centres 
in biology 
- Transition metals in supra-molecular 
chemistry 
- Molecular graphics and Ab initio 
calculations on iron-sulphur proteins 
- Molecular recognition and 
protein/protein interactions 
- Development of mimetics on 
fundamental biological processes 
- protein sequencing and homology of 
haem and iron-sulphur proteins 
- Automatic 3-D generation of molecules 
of pharmaceutical interest. 
FUTURE DEVELOPMENTS 
The PRAXIS XXI programme, from which the whole area of biotechnology will 
receive a major boost, will end in 1999. 

I i 
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UNITED KINGDOM 
CONTACT PERSON 
Dr. M.J. Geisow 
(coordinator, LINK Protein Engineering Programme) 
BIODIGM, 64 Langdale Grove, Bingham, Notts, NG13 8SS, UK 
Tel: 44 949 83 90 77 
Fax: 44 949 83 18 86 
Email: mbgei@seqnet.dl.ac.uk 
NATIONAL PROGRAMME/CENTRES 
Programmes 
-LINK Protein Engineering Programme 
-Directed Programme in Advanced Biomolecule Design 
Centres 
-Molecular Database (SEQNET) Daresbury Laboratory 
-Oxford Centre for Molecular Sciences Interdisciplinary 
Research Centre 
-Cambridge Centre for Protein Engineering Multidisciplinary 
Research Centre & the Unit for Protein Function and Design 
-Institute of Virology & Environmental microbiology 
- BBSRC', DTF, MRC' 
- BBSRC 
- BBSRC & EPSRC4 
- BBSRC & MRC 
-MRC 
-NERC5 
'BBSRC: Biotechnology and Biological Sciences Research Council, 2DTI: Department 
of Trade and Industry, 3MRC: Medical Research Council, 4EPSRC: Engineering and 
Physical Sciences Research Council, 5NERC: Natural Environment Research Council 
POLICY ASPECTS 
LINK Protein Engineering Programme 
This programme is a part of a government wide initiative (LINK) which aims to 
stimulate more investment by industry in research and development, to develop priority 
areas of potential benefit to the economy and develop technologies which cross 
boundaries in industrial sectors and scientific disciplines. The Programme is led by the 
Office of Science and Technology (OST). Funding is 50:50 public sector:private 
industries. Research must involve the design, production or application of proteins with 
novel propoerties, the discovery of protein structure/function relationships or 
development of enabling technologies. 
74 
BBSRC support for Protein Engineering 
The recent amalgamation of the Biological Sciences Committee and the Biotechnology 
Directorate, both of the former Science and Engineering Research Council (SERC) with 
the Agriculture and Food Research Council (AFRC) offers a great opportunity for a 
united approach to future Protein Engineering Strategy. The BBSRC is currently 
reviewing its strategy in Protein Science and bioinformatics as a whole. BBSRC will 
support both fundamental and strategic protein engineering. Protein engineering is a 
major theme at three BBSRC Research Institutes: Food Research (Reading), Babraham 
(Cambridge) and Nitrogen Fixation (Sussex). BBSRC also contributes to a national 
resource for users of molecular sequence and structure information and software tools to 
exploit these informatics resources at the Daresbury Laboratory (SEQNET). In addition 
instrumentation and facilities needed to advance protein engineering are supported. 
Contact Person: Dr. D. Yarrow BBSRC Polaris House North Star Avenue SWINDON 
SN2 1UH, UK, Tel +44 793 413200 Fax +44 793 413201. 
MRC support for Protein Engineering 
The MRC supports research across the spectrum of biological and medical sciences at 
its own establishments and universities. Its policy is to support basic research aimed at 
probing what can be discovered using the increasing power of protein engineering as 
well as research aimed at understanding particular molecules, whether involved in basic 
cellular processes or of potential practical importance to healthcare. Relevant areas 
supported are: high field NMR, protein crystallography, electron diffraction and 
molecular modelling for more effective design of drugs and vaccines. Relevant Centres 
are the MRC Centre for protein engineering (Directors A. Fersht and G. Winter) and 
The Cambridge University Protein Function and Design Unit (Hon. director A. Fersht). 
Contact Person: Dr. C. Moody, Research Management Group MRC 20 Park Crescent 
London WIN 4A1 UK, Tel +44 716365422, Fax +44 714366179. 
NERC support for protein Engineering 
The NERC supports basic strategic and applied research in the physical and biological 
aspects of the environment. This is aimed at understanding the processes within the 
natural environment which allow the substancial exploitation of natural resources. The 
NERC utilises the molecular biology experience of its Institute for Virology and 
Environmental Microbiology at Oxford for research on baculovirus expression vectors to 
produce proteins for diagnostics and candidate vaccines. This is basic and strategic 
research in support of the agrochemical, veterinary and healthcare industries. Contact 
Person: Dr. M. G. Schultz, NERC, Polaris House, Swindon SN2 1EU, UK, Tel +44 
793411800, Fax +44 793411502. 
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FINANCIAL ASPECTS 
The average Protein Engineering Programme and Centre expenditure per annum is 12 
MECU (Period 1989-1994). 
Link Protein Engineering Programme 
BBSRC Funding 
Oxford Centre for Molecular Sciences (IRC) 
Institute Research 
Standard Research Grants 
Directed Research Grants 
MRC Funding 
Cambridge centre for Protein Engineering 
NERC funding 
Institute of virology 
15.6 MECU (1989-1996) 
18 projects 
3.0 MECU per annum 
2.5 MECU per annum 
2.5 MECU per annum 
0.9 MECU per annum 
3.0 MECU per annum 
0.34 MECU (incl. CEC & private 
sector funds) 
SCIENCE &TECHNOLOGY ASPECTS 
Principal Investigator 
- Lowe/Sussex 
- Rees/Bath 
- Henderson/Cambridge 
- Findlay/Leeds 
- Campbell, Baldwin, 
Johnson/Oxford 
- Fersht/cambridge 
- Jackson/Nottingham 
- Thomton/UCL 
(London) 
- Taussig/Babraham 
- Goodenough/Reading 
- Thornaly/Sussex 
- North, Finlay/Leeds 
- Sayers/Scheffield 
- Begent/London 
- Hubbard/York 
Link Programme Projects: 
-ENDOR of Mn2+ ions in plants 
-Computer aided design and production of antibodies 
-Overexpression and structure determination of membrane 
proteins 
-Mechanism of G-protein linked receptors . 
-750MHz NMR; structures of oxygenases, SH2/3 domains, 
protein phosphatases and kinases 
-Protein structure and design 
-Development of STM for biomolecules 
-Conformationally restricted peptide design (based on 
predicted folds) 
-Design of anti-steroid antibodies 
-"Minimalisation" of an enzyme of commercial 
significance; Modifying the specificity of phospholipase A2 
-Structure and mechanism of chorismate synthase 
-Further development of a protein database resource 
-Bacterial display of rec-protein using endigenous export 
system 
-Understanding the immunogenicity of engineered 
antibodies 
-New molecular modelling interfaces (including virtual 
reality) 
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FUTURE DEVELOPMENTS 
LINK Programmes 
The Programme will end on or before 1996 and is 80% allocated. There is felt to be a 
need for a comparable programme to continue. Successor programmes are under 
discussion. One possibility is "Advanced biomolecular design", which would consider 
the engineering of other biopolymers (such as polysaccharides). Contact Person: Dr. 
M.J. Geisow (address above) 
BBSRC 
Genome research and advanced biophysical methods have provided the basis for rapid 
advances in understanding of biological function at the molecular level. This knowledge 
can now be exploited through the "rational" design of biomolecules. A greater 
understanding of biomolecules will provide many opportunities for industrial exploitation 
by the BBSRC user community in areas such as enzymes for industrial use, novel drug 
and pesticide design, the production of novel materials and the enhancement of food 
quality. Research in protein science supported by the BBSRC will include: folding 
modelling and design, molecular recognition and signalling, enzymes and catalysis, 
structural and storage proteins and production and degradation. 
MRC 
Genetic research is revolutionising studies in human biology, by leading directly to an 
increased understanding of disease and opening new routes to diagnosis and treatment 
across a wide range of conditions. As more sequence data becomes available (for 
example from the MRC Human Genome Mapping Project) it will be possible to extend 
the range of structure prediction and compare models with the experimental results of 
structures within the same protein family. Studies of molecular structure and function, 
including work on structure prediction, are central to industrial programmes to identify 
novel targets and develop more selective agents through the rational design of new 
ligands for key cellular proteins MRC will continue to provide training in protein 
engineering through state-of-the-art centres in order to meet the needs of both academic 
and industrial research. 
NERC 
NERC Protein Engineering using baculovirus expression vector systems offers new 
opportunities in the development of viral insecticides and vaccines; the study of viral 
morphogenesis; new diagnostics and more general studies of protein structure - function 
relationships. These activities will received continued support through the Institute of 
Virology. 
AUSTRIA 
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AUSTRIA 
CONTACT PERSON 
Dr. M. Hölbling 
Büro für Internationale Forschung und Technologiekooperation 
Wiedner Hauptstrasse, 76, A-1040 Wien 
Tel: 43 1 5811616-107 
Fax: 43 1 581 1616-16 
Email: bit-austria@bit.aconet.ada.at 
NATIONAL PROGRAMME 
•There is no specific programme, but related projects are financed by the Austrian 
Science Foundation (FWF - Fonds zur Förderung der Wissenschaftlichen Forschung-) 
• At the moment the FWF is evaluating two applications for the getting-up of special 
research programmes on "Computational structural biology" and "Determination of 3-
dimensional structure to atomic resolution of biomolecules" 
POLICY ASPECTS 
In 1991, the FWF, in cooperation with the Austrian conference of university presidents 
and the Federal Ministry of Science and Research, laid the foundation for special areas 
of research similar to the special research programmes in Germany 
("Spezialforschungbereiche"), thus clearly setting the stage for research priorities in 
Austria. 
This funding initiative has been intended to promote interdisciplinary long-term 
fundamental research (via bottom-up principle) by assembling scientists from designated 
disciplines at selected university centres and providing them with the necessary research 
apparatus thus improving the international competitivity. After a most rigorous 
international review process, the FWF board of trustees can approve such a special 
research programme 
FINANCIAL ASPECTS 
Approximately 2 MECU are allocated for the current projects related to protein 
engineering. 
The amount of future targeted national funding will depend on the decision of the FWF 
after the evaluation of the proposed special research programmes on "Computational 
structural biology" and "Determination of 3-dimensional structure to atomic resolution 
of biomolecules". 
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SCIENCE &TECHNOLOGY ASPECTS 
The 2 proposed special research programmes are: 
Computational 
structural 
biology 
University of 
Vienna, 
5 institutes 
- A. Beyer 
- D. Blaas 
- G. Buchbauer 
- G. Köhler 
- P. Wolschann 
- M. Neumann 
- P. Schuster 
- P. Stadler 
- 0. Steinhauser 
Determination of 
3-dimensional 
structure to 
atomic resolution 
of biomolecules 
3 universities: 
- Salzburg (M. 
Sippl) 
- Graz (C. Kratky, 
U. Wagner) 
- Innsbruck (Β. 
Kräutler, R. 
Konrat) 
University of Aprici) 
- X-ray crystallograp 
and engineering of a 
- Sequence structure relationships 
(Inverse folding of biopolymers, application of statistically derived 
potentials to protein folding problems) 
- Simulation methods 
(Efficient algorithms for handling electrostatic interactions in 
biomolecules, biomolecular hydration, continuum models and 
atomistics simulations, molecular dynamics, simulation of protein 
unfolding) 
- Applications 
(Kinetic and dynamic properties of host-guest systems, influence 
of ligand binding on the structure and dynamics of HIV-protease, 
surface accessability, energetics and conformation of peptides 
complexed to virus-neutralizing antibodies) 
- Data analysis 
(Molecular similarity and molecular surfaces) 
-Experimental determination of protein structures and other 
biological macromolecules 
-Development and application of knowledge based energy 
functions for protein modelling, fold recognition, prediction and 
simulation 
-Combination of experimental and computational methods in 
determination and engineering of structures of biological 
macromolecules 
Iture Vienna. Institute of applied microbiology (F. Rükerl 
hic structure determination, computer aided molecular modeling, 
ntibody-antigen complexes 
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FUTURE DEVELOPMENTS 
Future national funding will depend on the evaluation of the 2 proposed special research 
programmes and the decision from the Austrian Science Foundation (FWF), (decision at 
the beginning of 1995) 

FINLAND 
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FINLAND 
CONTACT PERSON 
Dr. T. Teeri 
VTT/Biotechnology and Food Research, PO Box 1503, 
Tel: 358 04565110 
Fax: 358 04552103 
Email: Tuula.Teeri@vtt.fi 
FI-02044 VTT 
NATIONAL PROGRAMME 
•TEKES (Technology Development Center of Finland) funded 2 national research 
programmes involving aspects of protein engineering: Gene Technology in 1984-1987, 
and Biotechnology in 1988-92 
•VTT (Technical research Center of Finland) funded an internal research programme of 
computer-aided molecular modelling in 1991-93 
•VTT carried out also part of the Protein Engineering Programme of the Nordic 
Industrial Foundation in 1989-93 
. The work initiated in the TEKES Biotechnology programme continues in closer 
industrial collaboration at both VTT and the University of Turku 
POLICY ASPECTS 
•Site-directed mutagenesis and the construction of fusion proteins are used as basic 
research tools in many academic institutes, research laboratories and R&TD laboratories 
in Finland. Protein engineering aiming to improve protein properties of immediate 
practical value is carried out at the VTT Biotechnology and Food Research Institute and 
at the Center for Biotechnology of the University of Turku which operate in close 
collaboration. 
•Supporting technologies include protein structure determination by X-ray 
crystallography (Universities of Turku and Joensuu) and multidimensional NMR (VTT 
Chemical Engineering and Institute of Biotechnology, University of Helsinki). VTT has 
a large molecular modelling group focussed on macromolecular modelling. 
•Two bulk enzyme producers, Genencor International Inc. and ALKO Ab, have 
significant interest in improving enzymes of industrial value. In addition, the diagnostic 
and pharmaceutical companies in Finland are actively engaged in protein engineering 
research aiming at improved diagnostic antibodies or drug design. These include eg. the 
Orion Corporation, Wallac Inc., Labsystems Inc. and Medix Biochemica. 
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FINANCIAL ASPECTS 
The amounts mentioned below include only grants for PhD students, post-docs, etc, 
and consumables (no equipment) and are estimations: 
- Biotechnology, TEKES, 1988-92: 1 MECU for protein engineering 
- Molecular Modelling, VTT, 1991-1993: 0.5 MECU for protein engineering 
- Nordic Industrial Foundation, 1989-1993: 0.2 MECU (Finland) 
Individual research projects have received approximately 0.5 MECU /year from 
different governments bodies and industrial partners 
SCIENCE &TECHNOLOGY ASPECTS 
The major facilities and projects concerned with protein engineering are listed below: 
VTT Biotechnology and Food Research, Espoo 
Projects on: cellulolytic enzymes, recombinant diagnostic and catalytic antibodies, ion 
channel receptors 
Relevant major equipment: two Silicon Graphics work stations (4D/35, Personal Iris), 
two IBM RISC6000 work stations (6000-32H, 6000-340) 
Local contact: Dr. Tuula Teeri 
tel. +35804565110, fax. +35804552103, e-mail: Tuula.Teeri@vtt.fi 
VTT Chemical Engineering, Espoo 
Relevant major equipment: A Varían Unity 600 MHz spectrometer equipped with two 
channels, two Silicon Graphics workstations (Indigo, Indigo 2) 
Local contact: Prof. Tor-Björn Drakenberg, tel. +35804565234, fax. +3580460041 
University of Turku 
Projects on: diagnostic antibodies, a-adrenergic receptors, inorganic pyrophophatases) 
Relevant major equipment: A RAXIS-IIC area detector mounted on a Rigaku RU-200 
x-ray generator with cryogenic cooling system for "flash-freezing", a small 
VAXcluster (DEC 3000AXP model 500, 2 VAX station 4000/60s, VAX 
station4000VLC), modelling work stations (Evans&Sutherland PS390, and ESV 
model30, Silicon Graphics Crimson with Elan Graphics) 
Local contact: Prof. Markku Jalkanen, tel. +358216338601, fax. +358216338000 
University of Helsinki, Institute of Biotechnology 
Relevant major equipment: Varían Unity 500 MHz spectrometer equipped with two 
channels, two Sun Sparestation 2s, a silicon Graphics workstation (Indigo) 
Local contact: Dr. Ilkka Kilpeläinen 
tel. +35804346089, fax. +35804346028, e-mail: Ikilpela@introni.helsinki.fi 
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University of Joensuu 
Projects on: Carbohydrate degrading enzymes. 
Relevant major equipment: X-ray diffractometer equipped with R-AXIS IIC area 
detector and RU200HB rotating anode. Several computers/workstations including 
EVand&Sutherland ESV3 and three Silicon Graphics Indigos 
Local contact: Dr. Juha Rouvinen, tel. +358731513318, fax. +358731513390 
FUTURE DEVELOPMENTS 
•Presently protein engineering research is not gathered under a national framework 
programme, but is integrated into different basic and applied projects many of which 
are carried out as a joint effort of several academic and industrial laboratories. These 
projects are primarily funded by TEKES, the Academy of Finland, and major 
industrial partners. 
Currently, major concerted projects involving protein engineering are in preparation 
under the framework of the "Graduate School" programme of the Academy of Finland 
(1994-1998). Upon the call for proposals of this programme (deadline August 15, 
1994), at least three large proposals focussed of protein structure, funciton and 
engineering and applied biotechnology will be submitted. 
•Contacts in the major bodies of funding: 
- Paula Nybergh, Research Manager 
Technology Development Center of Finland (TEKES) 
PO Box 69, FIN00101 Helsinki, Finland 
tel. +3580693691 
fax. +358069367793 
- Elisabeth Helander, Research Director 
The Academy of Finland 
Hämeentie 68, FIN00550 Helsinki, Finland 
tel. +358077488220 
fax. +358077488299 

ICELAND 
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ICELAND 
CONTACT PERSON 
Dr. A. Gudmundsdottir 
University of Iceland, Science Institute, Dunhagi 3, IS-107 Reykjavik 
Tel: 354 1694796 
Fax: 354 128911 
Email: ag@raunvis.hi.is 
NATIONAL PROGRAMME 
•There is no current specific National protein engineering research programm in 
Iceland. However, such activities have been funded within: 
- the basic science and biotechnology sectors of The Icelandic Council of Science, 
- the National Research Council of Iceland and, 
- the University of Iceland Research Foundation. 
(The Icelandic Council of Science and the National Research Council of Iceland have 
now been merged. The new council is the Research Council of Iceland) 
•Furthermore, Protein Engineering in Iceland was funded by the Nordic Industrial 
Fund, Umbrella Research Programmes during the period of 1990-1993 
POLICY ASPECTS 
Three institutes in Iceland are involved in protein engineering activities. These are: 
•The Science Institute, University of Iceland, 
•The Institute of Molecular Biology, Biology Institute, University of Iceland in 
collaboration with the Technical Institute of Iceland and, 
•The Institute for Experimental Pathology, University of Iceland, Keldur 
FINANCIAL ASPECTS 
The funding for the 3 above institutes is approximately 0.88 MECU for 3 years (1990-
1993). This includes the salaries of research associates but does not include 
infrastructure costs. 
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SCIENCE &TECHN0LOGY ASPECTS 
Three institutes are involved in protein engineering: 
Science Institute, 
University of Iceland, 
Dunhaga 3.IS-107 
Reykjavik, Iceland 
Fax: 354-1-28911 
- J.B. Bjarnason 
- A. Gudmundsdottir 
Laboratory of Molecular 
Biology, Institute of 
Biology, University of 
Iceland, Grensasvegur 12, 
IS-108 Reykjavik, Iceland 
Fax: 354-1-694069 
- A. Palsdottir 
- S. Thorbjamardottir 
Institute for experimental 
Pathology, University of 
Iceland , Keldur 
v/Vesturlandsveg, IS-112 
Reykjavik, Iceland 
Fax: 354-1-673979 
- B. Magnadottir 
- B. Gudmundsdottir 
- E. Gunnarsson, 
- 0 . Andresson 
- V. Andresdottir, 
- V. Steinborsdottir 
-Molecular mechanisms underlying the psychrophilicity 
(cold-adaptation) of serine proteases from Atlantic cod 
-Thermostable polysaccharide degrading enzymes from 
thermophiles 
-Thermostable DNA polymerases from thermophiles 
-Thermostable DNA ligases form thermophiles. 
-Clostridial beta-toxin for diagnostic and vaccines. 
-Molecular mechanisms underlying the virulence and 
antigenicity of an extracellular metallo-protease produced 
by a group of atypical strains of the bacterium Aeromonas 
salmonicida infecting various fish species. 
-Molecular clones of visna virus for diagnostic and 
vaccines. 
FUTURE DEVELOPMENTS 
A major reorganization of the Icelandic research councils is presently under way. The 
Icelandic Council of Science and the National Research Council have been merged and a 
new council formed named The Research Council of Iceland. Information regarding 
policy aspects of biotechnology and protein engineering programmes within the new 
Research Council of Iceland will be available by the end of 1994. 
NORWAY 
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NORWAY 
CONTACT PERSON 
Dr. S. B. Petersen 
SINTEF UNIMED, MR-Center, N-7034 Trondheim, Norway 
Tel: 47 73997700 
Fax: 47 73997708 
Email: SBP@MARVTN.MR.SINTEF.NO 
NATIONAL PROGRAMME 
There is none, but protein engineering is covered through biotechnology funding 
schemes directed by the Research Council. 
POLICY ASPECTS 
No national policy has yet been formulated, but a clear emphasis has been put by the 
Research Council on genetic engineering and, more recently, protein structure-function 
relationships. 
FINANCIAL ASPECTS 
Approximately 4 MECU have been allocated to protein engineering related activities 
since 1990. This sum also includes salaries for stipends and its has not been possible to 
separate the different cost contributions in the present analysis. 
SCIENCE &TECHNOLOGY ASPECTS 
All technological aspects of the protein engineering science are represented in Norway 
(18 projects were reported in 10 laboratories): 
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-X-ray 
- Genetic Engineering 
- Molecular Modelling 
-NMR 
- Sequence Analysis 
- Electrostatics 
- Tromsø 
- Tromsø, Trondheim, Bergen, Oslo 
- Trondheim, Tromsø, Oslo, Bergen 
- Trondheim, Oslo, Bergen 
- Trondheim 
- Trondheim 
Several groups are active: 
- Smalås/Hough, Univ. of Tromsø 
- Prydz, Biotechnology Center of Oslo 
- Krokan/Valla, Univ. of Trondheim 
- Martinez/Flatmark, Univ. of Bergen 
- Heiland, Univ. of Bergen 
- Skjeldal, Univ. of Às 
- Petersen/Drabløs, SINTEF UNIMED, 
Trondheim 
- Smidsrød, Univ. of Trondheim 
- Lindqvist, Univ. of Oslo 
-X-Ray 
- TF/FACT VIII 
- U-DNA-GIyc./PGM 
- Tyrosine Hydroxylase 
- HIV reverse transcriptase 
- Structure-function 
- Electrostatics, sequence analysis, NMR 
- Carbohydrate active enzymes 
- Phage display 
FUTURE DEVELOPMENTS 
The Norwegian Research Councils have recently been reorganized and new strategies 
and policies are expected to be formulated in the near future. 
SWEDEN 
ï if 
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SWEDEN 
Mr. L. Pettersson 
CONTACT PERSON 
NUTEK (Swedish National Board For Industrial and Technical 
SE-117 86 Stockholm 
Tel: 47 7997700 
Fax: 47 73997708 
(no Email) 
Development) 
NATIONAL PROGRAMME 
There is one programme funded by the Swedish National Board for Industrial and 
Technical Development (NUTEK). In addition projects in the area receive support from 
several research councils. A few companies are actively engaged in protein engineering 
research. 
POLICY ASPECTS 
Protein engineering is considered to be an area of high priority. Some projects are 
mainly problem oriented while in others the problem oriented research is combined with 
technology development. In the NUTEK programme an active involvement of 
companies is desired. 
FINANCIAL ASPECTS 
The annual public funding (excluding permanent positions and infrastructure costs) 
during the period 1992-1994 is about 2.5 MECU. In addition companies like Pharmacia, 
Symbicom and KaroBio are active in the field. Private funds are available for heavy 
equipment. 
SCIENCE &TECHNOLOGY ASPECTS 
The research covers all aspects of research related to protein engineering such as: 
- cloning, sequencing and mutagenesis 
- expression systems and purification methods 
- X-ray diffraction and NMR spectroscopy 
- molecular modelling and soft-ware development 
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The most important centers are: 
- The Biomedical Center of Uppsala 
(Prof. H. Eklund and A. Jones) 
- The Royal Institute of Technology in Stockholm 
(Prof. M. Uhlen) 
- The University of Lund 
(Prof. S. Forsen and A. Liljas) 
- The Center for Structural Biochemistry at NOVUM Karolinska Institute 
(Prof. T. Härd and R. Ladenstein) 
- Pharmacia Bioscience Center 
(Prof. B. Nilsson) 
Among the current research areas, we can mention the engineering of Ca2+ binding 
proteins, IgG-binding proteins, lipases, cellulases, RUBISCO, antibodies, peptide 
hormones and hormone receptors. The folding of several proteins is studied as well as 
the orientation of membrane proteins. 
In the neai 
"Fund for 
FUTURE DEVELOPMENTS 
future the area will most probably be strengthened 
strategic research". 
by funding from the new 
EMBL 
(European Molecular 
Biology Laboratory) 
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EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
CONTACT PERSON 
Dr. C. Sander 
EMBL Heidelberg, D-69012 Heidelberg 
Tel: 49 6221 387361 
Fax: 49 6221 387306 
Email: sander@EMBL-Heidelberg.DE 
PROGRAMME 
A European network of laboratories: 
All four EMBL laboratories are involved in aspects of protein engineering. The main 
laboratory in Heidelberg (DE) has several research groups in protein design, folding and 
engineering. The Hamburg (DE) and Grenoble (FR) Oustations specialize in the use of 
synchroton radiation for the solution of high resolution crystal structural and 
macromolecular complexes. The Cambridge (GB) Oustation is a European center of 
protein databases and will have research activities in computational protein design. 
Research groups at each laboratory are multinational and aim to spread expertise to 
European member countries through intensive training and carrier development of 
predocs, postdocs and relatively junior group leaders that may embark on careers in 
their national institutions after several years at an EMBL laboratory. 
POLICY ASPECTS 
. Access to larger scale facilities 
One of the aims of EMBL is the provision of access to European large facilities. In the 
area of protein engineering, visitors' and fellowship programmes are in place to provide 
access to beam lines at the two synchroton facilities used primarily for protein X-ray 
crystallography, the older Hamburg installation at DESY and the modem ESRF in 
Grenoble. In addition, EMBL will provide general access to structure refinement 
computer calculations on a multiprocessor machine in Heidelberg. 
. Integration of structure determination and genetic engineering 
Increasingly, single research groups integrate techniques such as X-ray crystallography 
and molecular genetics in support of protein engineering. This stems in part from 
technological developments easing the adoption of new techniques and in part from the 
wish to closely supervise all aspects of the protein engineering cycle under single 
leadership. 
104 
FTNANCIAL ASPECTS 
. Support from EMBL member countries 
Total expenditure of the EMBL laboratories in protein engineering is estimated to be 
about 0.8-0.9 MECU per year (not including group leader salaries). The precise amount 
is not known as the relevant research groups are also active to varying degrees in 
related disciplines, e.g., structure determination or mass spectrometry analysis of 
naturally occurring proteins. 
. External funding 
EMBL funding in protein engineering has been supplemented by grants from the 
European Commission under the BRIDGE and BIOTECH programmes, as well as from 
the German DFT and BMFT, and from specific collaborative arrangements with 
individual pharmaceutical companies. External support has amounted to approximately 
0.4 MECU per year. EMBL scientists have on several occasions acted as coordinators 
of collaborating European research networks funded by the European Commission. 
. Access to large scale facilities 
Recently, access to synchroton and high performance computing facilities has been 
supported by grants under the Human Capital and Mobility Access to Large Scale 
Installations programme of the European Commission. 
SCIENCE &TECHNOLOGY ASPECTS 
Particular projects are chosen independently by the individual research groups. 
Intergroup collaborative projects combining complementary expertise are common. 
. Groups involved in aspects of protein engineering: 
Tom Creighton (US,) Stephen Cusak (GB), Werner Kühlbranst (DE) Matthias Mann 
(DE), Hartmut Oschkinat (DE) Chris Sander (DE), Matti Saraste (FI), Luis Serrano 
(ES) Dietrich Suck (DE), Rebecca Wade (GB), Rik Wierenga (NL), Keith Wilson (GB) 
. Current protein engineering research areas: 
- redesign to elucidate the structural basis of function 
- redesign to understand the basic principles of protein folding 
- design and grafting of active sites 
- design of ligands for therapeutic use 
- de novo design to develop constructive principles of protein design 
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. Advanced instrumentation used in protein engineering: 
- X-ray crystallography, synchotron beam lines, 2-D detectors 
- Computing: multi-processor computers, computer graphics 
- NMR spectroscopy: 500 and 600 MHz spectrometers 
- Electron microscopy: two 200 kV instruments 
- Mass spectrometry: Electrospray triple quadrupole (ES MS/MS) and matrix assisted 
laser desorption/ionization MS with reflector time of flight analyzer 
. Proteins in engineering projects: 
These include: chemotactic protein cheY, trióse phosphate isomerase, lipase, subtilisin-
type protease, actin, DNAse, SI end PI nuclease, plant light harvesting complex LHC 
Π, interleukin-4, trypsin inhibitor ΒΡΤΊ, alpha-lactalbumin, cytochrome oxidase, SH3 
domains, rop, cytochrome P450, and serine tRNA synthetase. 
FUTURE DEVELOPMENTS 
. Protein structure research at EMBL Grenoble 
As a provider of access to high intensity X-ray beams for protein structure research at 
the ESRF, the Grenoble Outstation of EMBL will in the future take on increasing 
importance in structural biology research. Accordingly, the EMBL has committed 
significant financial resources to an expansion of the Grenoble Outstation in 1994/95. 
. Macromolecular Structure Database 
The new Cambridge Outstation of EMBL, the European Bioinformatics Institute, will in 
1995 begin building up the European component of the new Macromolecular Structure 
Database (MSD) that with its US partners will continue and extend the work of the 
Protein Data Bank. This database of protein and nucleic acid three-dimensional 
structures will be an important resource for protein engineering. Usefulness of the 
database will be increased through links to sequence and enzyme function databases and 
through the development of network information services related to protein structure and 
function. 
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. New techniques and new applications 
-Engineering membrane proteins: As techniques of structure determination improve, 
protein engineering at the EMBL is likely to expand into the reengineering of membrane 
proteins in the near future. 
-Emerging physical techniques: EMBL groups are making increasing use of mass 
spectrometry for protein engineering applications and are currently investigating the use 
of atomic force microscopy. 
-Structure-based design of molecular evolution experiments: In the next few years a 
major new contribution to protein engineering is likely to come from combining insight 
into D protein structures with the power of molecular diversity. In this emerging 
approach, proteins with novel function are developed in selection experiments in which 
the protein's genetic information is varied (randomized) at well-defined positions, 
followed by cell growth under stringently selective conditions. Groups at EMBL are 
currently involved in planning projects in the new area of designed molecular evolution. 
EUROPEAN COMMISSION 
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EUROPEAN COMMISSION 
CONTACT PERSON 
Dr. P. de Taxis du Poet 
European Commission , DG XII-E-1 (Biotechnology) 
me de la Loi 200, B-1049, Brussels, Belgium 
Tel: 32 2 295 40 43 
Fax: 32 2 295 53 65 
PROGRAMMES 
The ongoing BRIDGE (1990-1993) and BIOTECH (1992-1994) biotechnology 
programmes cover the protein engineering sector. The next biotechnology programme 
in the 4th Framework Programme (1994-1998) will include Stuctural Biology. 
POLICY ASPECTS 
•To strengthen the scientific and technological bases of Community industry and 
encouraging it to become more competitive at international level (article 130f of the 
treaty on European Union) 
•To coordinate the Community and the Member States research and technological 
development activities so as to ensure that national policies and Community policy are 
mutually consistent (article 130h of the treaty on European Union) 
•There are 2 types of protein engineering research projects: 
- basic research projects (or N projects) which are carried out for the integration of 
research efforts for tasks where the main bottlenecks result from gaps in basic 
knowledge 
- generic research projects (or Τ projects) which benefit from the combined 
contributions of different disciplines and techniques through efforts intended to remove 
important bottlenecks resulting from structural and scale constraints 
FINANCIAL ASPECTS 
The EC contribution for the protein engineering sector in the BRIDGE (1990-1993) and 
BIOTECH (1992-1994) programmes (not taking into account the BIOTECH 3rd call for 
proposals yet) is approximately 32 MECU*, corresponding to: 
36 projects including 180 laboratories 
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BRIDGE (3-year projects) 
BIOTECH (2 or 3-year projects) 
3.28 MECU (4 N-projects, 21 labs.) 
4.34 MECU (5 T-project, 23 labs.) 
17.39 MECU (20 basic projects, 107 labs.) 
4.92 MECU (7 generic projects, 44 labs.) 
•Including the contribution for projects on information infrastructures (protein 
sequence database, e t c . ) : 
- 2 N-projects in BRIDGE (1.17 MECU, 7 labs.) 
- 1 project in BIOTECH (1.2 MECU, 6 labs.) 
SCIENCE &TECHNOLOGY ASPECTS 
The following protein engineering topics are covered in the BRIDGE and BIOTECH 
programmes: 
BRIDGE Protein sequence databank, lproject / 1 lab. 
Integrated Europ. prot. struct, database, 1 project / 6 labs. 
Peptide lantibiotics, 1 project / 4 labs. 
Enzyme catalysis, protein stability and folding, 1 project / 4 labs. 
Triosephosphate isomerases, 1 project / 6 labs. 
Alpha-helical bundle proteins, 1 project, 7 labs. 
Lipases 3-D structure and catalytic mechanism, 5 projects / 23 lab. 
BIOTECH Validation of results of 3-D structural studies, 1 project / 6 labs. 
Enzymes associated with membranes, 6 projects / 32 labs. 
Antibodies-antigens interactions, 3 projects / 15 labs. 
Receptors, 6 projects / 30 labs. 
Metalloproteins, 3 projects / 18 labs. 
Protein engineering of lipases, (4 projects / 26 labs. ) 
Carbohydrate active enzymes (5 projects / 30 labs.) 
FUTURE DEVELOPMENTS 
Protein engineering activities are included, in particular, in the area 6 ("Structural 
Biology"), which is one of the 8 scientific areas of the Biotechnology programme of the 
4th Framework Programme (1994-1998). 
Projects proposals will be invited in the area of Structural Biology which is described in 
the Workprogramme as followed (the complete information package is available on 
request from the Commission services): 
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Area 6 - Structural Biology 
6.1 Structure-function relationships 
Objectives 
The primary scientific and technological objective is the understanding of how the 
function of biological macromolecules is related to their structure and spatial 
organisation, and the design of improved biomolecules with the desired properties. 
Towards this long-term objective, the approach followed in this area will focus on 
technological means irrespective of the types of molecules or subjects those means will 
be applicable to. 
Flexibility on subjects: a reasonable flexibility will be applied to the choice of 
biological macromolecules for these investigations, and to the subjects under study. 
They could, for example, cover protein folding, biocatalysis, membrane proteins, 
nucleic acids, carbohydrates, RNA, etc. This flexibility aims at mobilizing the scientific 
community of structural biologists , inviting the most promising and innovative 
research, and being capable of responding rapidly to the evolution of concepts. 
Technological requirements: The following constraints aim at enforcing synergies 
between different novel aspects of research in structural biology. The invited 
contributions should be multidisciplinary and systematically combine the three following 
facets of structural biology: 
- experimental determination of three-dimensional structures, 
- improvement of structure determination techniques and, 
- development of biochemical entities with the desired functions. 
Research tasks 
In view of the flexibility on subjects, and the requirements for technological inputs 
presented above, the proposals could address a wide spectrum of targets, provided they 
would address all three following topics to variable degrees (although one topic should 
become prominent in each proposal): 
6.1.1 Three-dimensional structure determination 
As the life sciences experts wished to stress, the systematic experimental determination 
of many more three-dimensional structures of biological macromolecules and complexes 
of macromolecules (such as proteins, DNA, RNA, carbohydrates or lipids) will form 
the basis of our developing knowledge of the relationships between primary structures 
and the tertiary structures of biologically active macromolecules and, even more so, the 
quaternary structures of the multi-subunit complexes which mediate most biological 
activities. The complementary need to store, retrieve and analyze the rapidly 
accumulating biomolecule structural information is taken into account in Area 8 
(Infrastructures). 
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6.1.2 Improvement of techniques 
The improvement of techniques, such as X-ray diffraction, NMR, mass spectrometry, 
etc, for experimental 3-D structure determination of biological macromolecules and the 
growing size of structures that they can assess will allow, for example, better resolution, 
and work on subcellular structures, with further implications for an understanding of 
biological functions within the cell. Synergies and complementarities between the 
different techniques are invited in the proposals. Of particular importance for the 
improvement of techniques is synchrotron radiation for macromolecular 
crystallographers which allows more accurate data to be obtained. Because synchrotron 
radiation facilities are particularly suited to serve multinational interests through 
collaborative projects, proposals including the cost of operating such facilities would be 
welcome, particularly when this leads to novel and challenging experiments (e.g. very 
small crystals and rapid data collection). 
6.1.3 Biomolecules with the desired functions 
The discovery and refinement of new biochemical entities with desired functions will 
consider both terms of the following alternatives : 
-rational design, including de novo design, of biomolecules with specific 
structural,chemical or catalytic properties, which requires a detailed understanding of 
and control over biomolecular conformation and reactivity. 
-in vitro selection technologies of natural or de novo designed structures by their binding 
or catalytic activities, consisting in a large, heterogeneous pool of biomolecules 
subjected to multiple rounds of selection and mutation. This includes, for example, 
display of proteins on the surface of filamentous phage, or in vitro directed molecular 
evolution to select RNAs with catalytic or affinity properties. 
6.2 Interface of structural biology with electronics 
Objectives 
The emerging interface of biology and electronics will be explored with a view to allow 
the interplay of competencies in structural biology and micro- and nano-scale 
engineering towards new possibilities of designing functional units which could 
incorporate modifications at the scale of the nanometre. In this domain, the invited 
contributions should in priority reduce the huge gaps which still exist between groups 
which deal with: 
- micro or nano device fabrication in materials and, 
- biological systems where structural biology is of key importance. 
Research tasks 
77ie systematic combination of groups of material engineers which deal with micro or 
nano device fabrication, and groups of "bioengineers" which deal with biological 
molecules is requested in the invited contributions for this research task. Priority will 
be given to the study of the interface of man-made structures and biological 
molecules, including the following scientific and technological topics: 
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6.2.1 Signal transduction 
The signal transduction, in particular, electrical and optical signals, between 
biomolecular functional units and man-made substrate structures, including, for 
example, direct electron transfer between metals and redox enzymes. 
6.2.2 Improvement of experimental tools 
The improvement of non-destructive techniques with high spatial and time resolution 
which, for example, characterise bio-active interfaces (structure, function, stability) and, 
the design of miniaturized transducers for devices based on biological function. 
6.2.3 Research on new applications 
The molecular nanostructure engineering, combining nanotechnology and biosystems, 
will be explored in order to lead to new generations of applications. Here, the task is 
not to develop a specific application or product but rather to acquire the basic 
understanding necessary to detect and highlight new opportunities for applications which 
can emerge from the following symbiosis between biosystems and nanotechnology: 
-biological molecules present properties (for example, the tendency to self-assemble into 
highly organized two- and three-dimensional structures) which are highly attractive in 
today's drive for new engineering materials and, 
-nanotechnology offers new tools to study biological molecules, to perform micro-scale 
biochemistry, to manipulate cell components and to render macromolecular structures 
able to controlling their activities or function (for example, in the field of biosensors). 
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Analysis of European Protein Engineering R&D Programmes 
Abstract 
The European Commission has asked nationally appointed experts in the area of Protein 
Engineering (PE), from 16 European countries that are fullparticipants in the European 
research programmes, to analyse the current organisational status of PE in Europe. The 
Commission has specifically stated that it wants to describe those organisational and 
technological aspects of the various research programmes involving PE. The present 
consensus document is, to a large part, based upon cautious analysis of data that has been 
provided by the individual experts. The nature of the present task requires that common 
trends rather than individual exceptions are highlighted, except when the nature of such 
exceptions may contain an important message for the report as a whole. 
. The organisation of Protein Engineering 
Only a minor proportion of European countries have dedicated protein engineering 
programmes (Denmark, France, The Netherlands, Sweden and United Kingdom). Two 
countries (Germany and Japan) and the European Commission have programmes which, in 
effect, include applied protein engineering or underpinning technologies (i.e. projects in 
BAP, BRIDGE and BIOTECH). Belgium, Finland and Spain have national programmes, 
which include protein engineering. Six countries (Denmark, France, Germany, the 
Netherlands, Norway and United Kingdom) have allocated funding for specific topics in 
protein engineering to selected centres. Finally the European Molecular Biology Laboratory 
and its outstations have received funding that has allowed some scientific groups to pursue 
protein engineering research. From 1989-1993 the Nordic Industrial Foundation (Denmark, 
Finland, Iceland, Norway and Sweden) carried out a specific programme for Protein 
Engineering. This information is summarized in Table 1. 
. Policy aspects 
PE is clearly being worked on in all the countries surveyed, whether or not a specific 
national programme or centres for PE can be identified. The setting up of special initiatives 
or centres of excellence (in those countries which have them) probably resulted from policy-
makers recognising the strategic relevance of PE as well as the medium- to long-term 
importance of modified proteins in the biotechnology and pharmaceutical markets. Industries 
have been very influential in those countries that do have national programmes and centres 
for PE. 
. Financial aspects 
In each of the 16 countries, substantial funding has been made available for PE activities, 
both for capital equipment, infrastructure costs and research programme grants. The funding 
schemes are all of finite length, in many cases consisting of 5-year programmes. Some of 
these are actually ending or will end within 1-2 years. 
Due to seemingly very different methods of accounting for PE funds, an accurate 
comparison of national and international financial committments is very difficult to obtain. 
The total national annual spending has been estimated by the national representatives. When 
the numbers are analysed per head of national population, a baseline figure of 0.2-0.3 ECU 
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per capita appears as a plausible average figure, in particular in the countries that have 
recognised national PE programmes. The level of funding broadly reflects the size of the 
economies as one would expect. However, in countries where funding is very low, this may 
also reflect a lack of government awareness of the strategic importance of PE. Further 
support for this view comes from our observation that the development of national 
programmes correlates with countries that already have a substantial established 
biotechnological or pharmaceutical industry. 
As is evident from the BRIDGE and BIOTECHNOLOGY programmes, countries with no 
national programmes or centres relay heavily on their European partners for access to 
resources unavailable or in short supply in their own countries. Such a lack of local provision 
of resources seriously inhibits progress. 
. Complex funding routing 
There is evidence of a wide variation of coordination of PE activities within countries, 
without even considering the question of transnational coordination. This variation seems to 
arise from factors related to the different sources of funding: governmental (Federal vs. 
State difference); sectoral (public sector bodies, research councils, charities) and traditional 
(trade, chemistry, biology, medicine, food and agriculture). In essence, the links and 
communications between these different communities have always been relatively weak. This 
makes the coordination of a multidisciplinary, cross-sectoral field of endeavour like PE quite 
difficult in some countries. It also makes it unnecessarily difficult for the individual 
researcher to obtain grants, since PE does not have any obvious single association with a 
particular granting body - thus applications are often deferred to other bodies. 
. The industrial interest and activities in PE 
Many industries do not have in-house protein structure determination or macromolecular 
modelling facilities whereas national PE programmes and centres all have a strong emphasis 
on instrumental and computational methods as well as integrating the necessary molecular 
biology, protein purification and production. Many small and medium sized industries 
(SMEs) rely upon publications by or collaborations with universities or research institutes. 
The largest biotechnological and pharmaceutical industries have indeed set up most or all 
such facilities in-house. Shortage of time has prevented a thorough review of the industrial 
contribution to PE in Europe - this will be addressed in the next report to be published by 
the European Communities. 
. Science and technology towards future developments 
The methodologies involved in Protein Engineering are viewed as a group of enabling 
technologies for the future of European Biotechnological and Pharmaceutical sciences. Thus, 
lhe panel recommends that further strengthening and consolidation of the European part of 
these methodologies is secured through the EC as well as national funding. The necessary 
research is of a fundamental nature, and there is a clear need for long term programmes 
funding such research. 
Protein Engineering is essentially a complex science that encompasses several recent 
technological achievements. Our understanding of structure-function relationships of proteins 
is not advanced enough to enable us to rationally design proteins with the function required. 
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In order to increase this understanding, the panel favours an overall approach, widely open 
to a large spectrum of methodologies, biomolecules, types of interaction, etc, from which 
a variety of inputs could be obtained. 
Future achievements will depend on a concerted development of the component technologies 
of protein engineering. In this context, it should be stressed that the importance of the 
individual technologies may change since new technologies are constantly emerging. 
Particular attention should be given to the emergence of the growing alternative to rational 
design, consisting of selection technologies, such as protein phage display or in vitro directed 
molecular evolution which mimics Darwinian evolution at the molecular level. The 
complementarity and synergy between rational design and these selection technologies are 
stressed. 
The area of protein engineering should therefore be monitored continuously by the European 
Commission. In order to facilitate a continuous monitoring, the panel suggests that a 
European Organisation of Protein Engineering Centres (EPEC) should be established, with 
support from the Commission. 
The Group identified several technologies that should be considered. Below is a non-
prioritized list: 
.Mass spectrometry should be recognized as an emerging technology for Protein Engineering 
. Technologies for studying structure of membrane and other non-soluble proteins. These 
inclide 2D Cryoelectron microscopy, atomic force microscopy and related techniques for the 
study of shape and actions of proteins 
.System level nanostructure engineering. Clear possibilities for industrial interest in the 
integration of micro electronics and biological systems are emerging. Active communication 
links with R&D activities in the electronics industry should be established. 
.Studies of molecular recognition should be given high priority. Techniques for the 
characterization and monitoring of protein surfaces are important. The intrinsic role of 
electrostatic interactions between a protein and its substrate should be studied. 
.Technologies should be developed for the incorporation of non-natural amino acids which 
would enhance the abilities of PE to develop totally new structures with novel functional 
properties. 
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Table 1: Protein engineering programmes and specific funding for selected centres in 
Europe 1985-1994. INPEC is International Protein Engineering Centres and 
NI programme is Nordisk Industrifonds Protein Engineering Programme 
(1989-1993). 
Countries 
Austria 
Belgium 
Denmark 
Finland 
France 
Germany 
Greece 
Iceland 
Ireland 
Italy 
The Netherlands 
Norway 
Portugal 
Sweden 
United Kingdom 
EC 
EMBL 
National 
Protein 
Engineering 
Programmes 
YES 
YES 
YES 
YES 
YES 
Specific Protein engineering funding for 
selected centres 
YES - INPEC member, Nl programme 
NI programme 
YES - INPEC member 
YES - INPEC member 
NI programme 
YES - INPEC member 
NI programme 
NI programme 
YES - INPEC member 
OVERVIEW IN OTHER COUNTRIES 
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Overviews in other countries (USA, Canada and Japan) 
The following information has been obtained through the "EC-US Task Force in 
Biotechnology", in particular following the fourth meeting of the task force on 18-19 October 
1994, and from INPEC (International Network of Protein Engineering Centres). 
. Support of Structural Biology and Protein Engineering research in the USA 
The US Federal Biotechnology Research Initiative does not treat structural biology or protein 
engineering as separate sectors. Instead, they are embedded in the principal biotechnology 
research areas: 
-Agriculture; 
-Energy; 
-Environment; 
-Healthcare; 
-Manufacturing/Bioprocessing (Relevant major themes are: understanding enzyme structure-
function relationships to tailor proteins for particular purposes; employing remodelling 
techniques to improve product design; molecular simulations and stable biosensors for in-
process use) 
-General Foundations (Underpinning research) (Relevant themes are: biochemical and 
biophysical technique development (new methods for identifying, synthesizing, purifying, 
characterizing and manipulating nucleic acids, proteins and other biomolecules; instrument 
development, especially for studying macromolecular conformation and chemical structure-
information research and development (methods for storing, processing and analyzing 
biological data). 
Current priority areas are: Health (therapeutic agents developed through recombinant DNA 
technology; vaccines and molecular nuclear medicine) and the Environment (Bioremediation, 
monitoring/biosensors and environmentally friendly pesticides). 
Support for protein engineering and structural biology is also derived from the budget for 
infrastructure (Relevant themes are the provision and maintenance of databases of DNA and 
amino acid sequences and the 3-dimensional structure of proteins): Facilities; Training; 
Instrumentation; Repositories and Databases/Reference Standards. 
Structural Biology is a major emphasis for at least three federal agencies, the National 
Institutes of Health (NIH)* the National Science Foundation (NSF) and the Department of 
Energy (DOE). The Howard Hughes Medical Institute (HHMI) is also a major source of 
funding for research in the area of structural biology. The National Institute for Standards 
and Technology (NIST) at the Department of Commerce (DOC) supports a major structural 
biology programme through its Centre for Advanced Research in Biotechnology (CARB). 
CARB is the USA member of the International Network of Protein Engineering Centres 
(INPEC). The multiplicity of agencies with various missions ensures coverage of the many 
aspects of structural biology needed for an effective programme. 
'There are approximately 20 independent institutes that comprise the National Institutes of 
Health. Each has its own independent budget and distinct mission. Those institutes with a 
significant interest in Structural Biology include: the National Centre of General Medical 
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Sciences (NIGMS), the National Centre for Research Resources (NCRR), the National Cancer 
Institute (NCI), the National Institute of Diabetes and Digestive and Kidney Diseases 
(NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National 
Library of Medicine (NLM) and the National Institute of Arthritis and Musculoskeletal and 
Skin Diseases (NIAMS). 
Research: All of the federal agencies cited above fund grants to individuals within institutions 
to do research in the area of structural biology. Funds are made available on application and 
a favourable peer review of the grant application. Individual research grants are favoured in 
most of the Institutes within NIH and NSF. The bulk of HHMI research support is given to 
HHMI investigators. These investigators are selected and are actually employees of HHMI. 
At least for NIH, applications from foreign institutions are accepted. 
Infrastructures: The vitality of Structural Biology is dependent on the health of shared 
facilities, for example, such synchotron facilities and databases as the Protein Data Bank. 
Funding for synchotron beam lines comes primarily from DOE. Funding for the individual 
stations is available from DOE, NSF, NCRR (of the NIH) and HHMI. Funding for the 
Protein Data Bank comes primarily from NSF with significant cofunding from NIH (NLM 
and NIGMS) and DOE. The development of validation software is funded by the EC. 
Training: The National Institute of General Medical Sciences has an Institutional Predoctoral 
Training programme in the area of Molecular Biophysics funded by the Office of Aids 
Research, NIH. Individual postdoctoral fellowships are also funded. By legislation these are 
available only to US citizens and resident aliens. Special programmes for foreign visitors are 
available through the Fogarty International Centre (contact Dr. David Wolff, 
+1.301.496.1653.) NSF funds institutional predoctoral training grants, individual predoctoral 
fellowships and individual postdoctoral fellowships. There are special programmes available 
for foreign visitors. (Information about NSF programmes is conveniently available from the 
NSF gopher hole). In addition to formal training programmes, significant numbers of 
predoctoral and postdoctoral trainees are supported on individual NSF and NIH research 
grants. 
Instrumentation: Shared instrumentation is funded through special programmes at NSF and 
NCRR. Dedicated instrumentation is funded through individual research grants. A particular 
problem exists with the funding of very expensive pieces of equipment, especially if it cannot 
be shared among several laboratories. 
New Initiatives: 
- Vaccine biotechnology (enhancement of immunogenicity) 
- Novel computational tools for structural biology 
- Microgravity crystal growth and separation processes 
- Bioelectronics and Bionetworks 
- Biomaterials 
Financial Aspects: It is not possible here to single out funds allocated to Structural Biology 
from the FY 1994 allocation. However, the major agencies active in this area are: NIH; 
DoE; NSF. Funds allocated by these agencies in the area of Health, 
Manufacturing/Bioprocessing and Databases are: 1.7 $bn. 
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. JAPANESE Protein Engineering & Biomolecular Engineering 
- Protein Engineering Research Centre (PERI) 
PERI is the national protein engineering centre, endowed by the Japan Key Technology 
Centre in 1986 as the world's first exclusive, integrated centre for Protein Engineering. PERI 
is a joint venture of Japan Key-Tech and 14 industrial firms. The Centre recently learned that 
continuation of its funding (previously somewhat in doubt) has been approved to: 17.1 Ybn 
(1986-1996). 
PERI is organised into 5 research departments which reflect the progress of research from 
the isolation of a natural protein through to expression of engineered forms: 
1. Structure analyses (X-ray, NMR, cryomicroscopy) 
2. Structure-function correlation (Molecular graphics, protein design) 
3. Protein modification and biosynthesis (DNA methods and intracellular transport). 
4. Protein characterization (sequencing, post-translational modification analysis). 
5. Databases (Protein modelling, structure prediction) 
Current themes are: structure determination; molecular simulations; protein folding 
computational structural biology; protein design and synthesis; protein stabilization; high 
performance catalytic antibodies and structural analysis and application of membrane 
proteins. Technology transfer is arranged by six laboratory annexes of PERI which were 
created at the research institutes of participating firms. Work has also been initiated at PERI 
by seconded academics and industrial scientists. 
Future developments include: more application in chemicals, electronics, environmental 
safety and pharmaceutical industries; downsizing of proteins by protein engineering and 
chemical synthesis of modified proteins. 
- Biomolecular Engineering proposed initiative for 1994 
The "Association for the Progress of New Chemistry" investigated the theme "Biomolecular 
Engineering" during FY 1993: "Due to recent advances in proteins, nucleic acids, 
carbohydrate and lipid science, research should be initiated to construct a framework for 
research into the mechanisms of biomolecular function. An aim could be the downsizing of 
biomolecules to create more stable economic materials retaining functionality. Particular 
applications are in chemistry, environment, information, machine, electronics, food-
agriculture, forestry, fishery and medicine". 
The BEP (Biomolecular Engineering programme, 1995-2005) will receive 26.4 bn yen net 
for: Preliminary research (-1995), Expression and structure-function analysis (1996-1998), 
and Downsizing & multi-functional protein assemblies (1999-2004). 
The research targets are: low energy - loss production schemes, artificial (novel) enzymes, 
biodegradable polymers, means to degrade persistent materials (pollutants), stability towards 
solvent and heat, creation multiplicity (LSI) and polyfunctionality, novel medicines and 
diagnostics, biocomputers, and high sensitivity monitoring. 
A major concept of the Biomolecular Engineering programme is that of "downsizing" 
functional protein units, stabilization of structures towards loss of function and assembly of 
engineered biomolecules into multi-functional assemblies (Large-Scale Integration LSI). 
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. The Protein Engineering Network of Centres of Excellence (PENCE) in CANADA 
Support for protein engineering comes from a number of federal and provincial sources but 
mainly through a programme run by the Medical Research Council of Canada and the 
Natural Sciences and Engineering Research Council of Canada. Their programmes are 
available to other life science applicants. 
Set up in 1990, the Protein Engineering Network (PENCE) is a multidisciplinary consortium 
of university, government laboratory and industrial scientists across Canada researching the 
relations between the molecular structure and function of proteins by chemical and molecular 
biological synthesis of systematically modified proteins. 
Major Achievements: 
- Leads for a potential drug against inflammation 
- Developing method for automated synthesis of oligosaccharides (joint venture) 
- Developing novel drug delivery technology using chemical crosslinking of proteins (joint 
venture) 
- Developed improved engineered enzymes which reduce amount of chlorine used to bleach 
wood pulp 
Description of research: 
Protein Engineering is a multi-disciplinary science whose overall aim is to modify the 
structures of proteins. Initially, modifications are designed to reveal details of the relationship 
between structure and function in proteins. Thereafter, modifications are intended to improve 
the utility of proteins for commercial and therapeutic use. PENCE'S programme covers all 
aspects of protein engineering, grouped into 7 major areas: 
1 - Growth Factors, Receptors and Signal Transduction 
Growth Factors are of enormous interest to the pharmaceutical industry because they 
represent targets for development of effective therapies for allergic diseases, tissue repair and 
cancer. PENCE researchers focus on 3 of 70 or so cellular growth factors as well as the SH-
2 and SH-3 domains involved in intracellular signal transduction. Approaches to the study 
of IL-8, IL-5 and TGFor include the determination of their structures and synthesis of 
analogues, coupled with biological studies. This work is providing new insights into receptor-
subunit interactions, receptor activation and sites of protein/protein interactions in 
downstream signal transduction molecules. 
2 - Proteinases of Disease 
Proteinases, enzymes which break down proteins, are involved in many diseases in which 
aberrant protein turnover occurs. These include muscular dystrophy, bacteria] infections, 
stroke and myocardial infarction. PENCE researchers are developing a database of structural, 
enzymological, mechanistic and chemical knowledge on the cysteine proteases and are using 
this information to design non-peptidyk inhibitors and other lead compounds for therapeutic 
development. 
3 - Vaccines and Immunological Products for the Treatment of Infectious Diseases 
PENCE researchers are developing novel vaccines and therapeutics for the prevention of 
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significant viral and bacterial infections. A "rational design" approach based on extensive 
structure-function studies of key virulence factors is being used to generate technologies upon 
which development of new classes of vaccines and therapeutics will be based. It is anticipated 
that the technology will be generally applicable for the development of vaccines directed 
against a variety of pathogens. 
4 - Carbohydrate-based technologies 
A number of distinct projects, unified by their common basis in carbohydrate/protein 
interactions, are being pursued. These include the development of specific cellulose-binding 
proteins as affinity ligands for protein-based therapeutics, or as newspaper de-inking agents; 
the development of novel enzymatic approaches for synthesis of oligosaccharides and the 
development of glycosidase inhibitors as therapeutic agents. 
5 - Metalloproteins for Industry and Medicine 
Environmental concerns have focused attention on ways to remove lignin from woodpulp at 
the same time as reducing the use of potential environmentally damaging chlorinated 
compounds. PENCE researchers are studying a number of enzymes that share the ability to 
delignify wood. Other metalloproteins which ordinarily fulfill critical roles in ligand 
transport (haemoglobin and myoglobin) are being studied for possible use as drug delivery 
agents. 
6 - Protein Design 
PENCE researchers are studying how proteins fold into their biologically active 
conformations. This knowledge is applied to the design and synthesis of synthetic peptide 
vaccines and to the design of synthetic mini-globulins for diagnostic and therapeutic 
applications. 
7 - Protein Structure and Function Technology Development 
Central to the successful use of protein engineering is the use of a wide variety of rapidly 
developing and sophisticated technologies. The overall objective is to develop three of these 
technologies: automated approaches for the analysis of NMR spectra; NMR approaches to 
the characterization of protein dynamics; and peptide-based technologies. 
Current Industrial Involvement: PENCE researchers are working with the following 
companies: 
- Allelix Biopharmaceuticals 
- Biomira Inc 
- Connaught Lab. Ltd. 
- GlycoDesign Inc. 
- Hemosol Inc. 
- Hypercube Inc. 
- Merck Frosst Canada Inc. 
- PAPRICAN 
- Symphar Inc. 
- Synthetic Peptides Inc. 
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Conclusion 
The 1994 report on protein engineering programmes in Europe should be considered as the 
first step in a continuous approach towards providing better information for the scientific 
community, programme managers and policy makers involved in protein engineering R&D 
in Europe. 
As a first step, this report has deliberately chosen to focus on a rather specific target (the 
national protein engineering programmes or the protein engineering parts of wider national 
programmes), therefore ignoring important aspects of the development of protein engineering 
such as the overall context (in particular, the industrial context) in which the national 
programmes are implemented. 
The initial limited scope may be enlarged and modified for future reports (such as the 1995 
one). Indeed, the contact group has already pointed out the need to take into account the four 
following aspects: 
The nature of collected information did not lead, in the present report, to answer the question 
"What do we know about Protein Engineering ?" and thus a scientific "state of the art" 
report, but rather to answer the question "How is Protein Engineering research organized 
in each European country ?". These two aspects clearly depend on each other and a balance 
should be reached between them in the next report in terms of information collected and 
inputs received from the scientific community. 
The "receivers" ofinformation should not be limited to the European Commission services. 
Indeed, all policy makers and programme managers in European countries as well as the 
European scientific community are potentially interested. Reactions and suggestions are 
invited from this large potential audience and should be taken into account to improve the 
quality of the next report. 
The scope of protein engineering seems to be too limited to efficiently address the various 
activities related to the basic problem of structure-function relationships. This problem is 
the same for all biological macromolecules and, very often, various types of biomolecules 
interact with each other as well, so the border lines between the different types of 
biomolecule become unclear (such as catalytic activities supported by enzymes and also 
abzymes). It is therefore suggested that the scope be extended to the wider area of structural 
biology, including types of biological macromolecules, other than proteins; 
The industrial aspects of R&D activities should also be taken into account, both upstream, 
as an important element influencing R&D programmes and policies, and downstream, as a 
contribution to the improvement of competitivity. 
Concurrently with the present report, the "Protein Engineering Contact Group" is now 
established, which has meant the emergence of a group of persons sharing information, 
discussing policies, etc, and therefore creating a "tool" that contributes to the coordination 
of research in Europe. The role of this "Contact Group" is crucial to the improvement of the 
quality and accuracy of information, and for the formation of a network, together with the 
European Commission services, so that it hopefully becomes an instrument of further and 
deeper coordination. 
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PUBLICATIONS AND REPORTS 
The following publications and reports on protein engineering in Europe aim to reflect the 
general context, as well as reveal pre-existing relevant information or initiatives in the 
development of protein engineering in Europe. 
International 
The International Network of Protein Engineering Centres (INPEC) is an unofficial group of 
national centres concerned with protein engineering research, which was established on May 
1991. The INPEC centres are the: 
- Cambridge centre for protein engineering, Cambridge, England 
- Centre for advanced research in biotechnology, Rockville, USA 
- Centre for applied protein engineering, Braunschweig, Germany 
- Danish protein engineering research centre, Aarhus, Odense, Copenhagen, Denmark 
- Laboratory for protein engineering (P-2000), Paris and Grenoble, France 
- MR-centre for protein engineering, Trondheim, Norway 
- NRC centre for protein structure and design, Montreal & Ottawa, Canada 
- Protein engineering research institute, Osaka, Japan 
Each country may have up to one node within INPEC. Each node is encouraged to 
communicate its country's activities in protein engineering to INPEC and to disseminate 
information on INPEC's activities throughout the node's country. 
The aims of INPEC are the: 
- Promotion of basic and applied research in the field of protein design 
- Mutual cooperation and exchange ofinformation to avoid duplication of research 
- Organization of annual international protein engineering meetings 
- Exchange of scientists 
- International training at the post-doctoral level 
Europe 
Protein Science & Engineering in Europe, 
M. Geisow 
Report & Position paper, Meeting at GBF, Braunschweig (DE), 4-5 May 1993 
European Research Programmes in Protein Engineering: Past, Present and Future 
P. Woolley and B.F.C. Clark 
Biotec (Milan; pubi. Clas International, Brescia), May 1989, pp. 35-41 
Ingénierie des protéines: des stratégies nationales pour une recherche précompétitive 
J-C. Pinon 
Biofutur, February 1989, pp.6-10. 
Europe's shining new light 
N. Hall 
New Scientist, 14 March 1992, pp. 30-33. 
136 
Nordic Countries 
Nordic Programme for research and Dissemination of Technical Expertise in Protein 
Engineering 
4th. annual report: May 1992-April 1993. 
France 
L'ingénierie des protéines: place de la France dans la compétition internationale 
CADAS (Comité des Applications de l'Académie des Sciences) 
Rapport n '12, juin 1991. 
United Kingdom 
Newsletters: 
Peptide: Quaterly publication of the UK Protein & Peptide Science Group (Biodigm, Unit 
5, the Hillside Centre, Upper Green St. High Wycombe Bucks HP11 2RB). 
Perspective on protein engineering (Bi-annual publication of the LINK Protein Engineering 
Programme) address as above. 
ANNEX 2 
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